FINAL PROGRAMME - Esc-archive.eu

12 th
European
Stroke
Conference
Valencia, Spain May 21 – 24, 2003
www.eurostroke.org
FINAL PROGRAMME

Acknowledgements
ESC expresses its thanks and appreciation to those companies and organisations which are
generously contributing to the success of the 12 th European Stroke Conference:
Sanofi-Synthelabo / Bristol-Myers Squibb
Boehringer Ingelheim
NMT Medical
Ferrer Group
Bayer Health Care
Grupo Uriach
Pfizer
Cochrane Stroke Group /
Stroke Unit Trialists Collaboration /
European Stroke Unit Group
Novo Nordisk
MSD
Cerebricon
Bioscience Ediprint
DWL Elektronische Systeme
Wisepress Bookshop
S. Karger

Contents
Welcome Address . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 2
Committees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 3/4
Important Addresses . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 5
Scientific Programme at a Glance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 6–9
Scientific Programme
– Wednesday, May 21, 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10–14
– Thursday, May 22, 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 15–26
– Friday, May 23, 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 27–45
– Saturday, May 24, 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46–53
Poster Sessions
– Thursday, May 22, 2003 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 54–78
– Friday, May 23, 2002 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 79–105
Instructions for Authors
– Oral Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 106
– Poster Presentations . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 107
Welcome Reception . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 108
Accompanying Persons Programme . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 109
General Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 110–116
Conference Venue Overview . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 118
List of Exhibitors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 119
Exhibition and Conference Venue Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 120/121
Valencia Sights . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 122/123
13 th European Stroke Conference ESC 2004
May 12 – 15, 2004
Mannheim / Heidelberg, Germany
1

Welcome Address
Dear Colleagues and Friends,
It is certainly an honour and a great privilege to welcome you to Valencia to attend the
12th European Stroke Conference.
The European Stroke Conference is one of the most important neurological meetings in
Europe, and with its specific dedication to cerebrovascular diseases it has managed to
attract a huge attendance. Participants are not only clinicians but also some other multiple
research and health care professionals who deal with the multifaceted aspects of the
stroke. The conference programme includes special lectures, symposia, teaching courses,
platform and poster presentations. It is our intention to keep alive the spirit of lively
discussions, which forms part of the most intimate soul of these meetings.
We hope this conference will allow us to improve our skills in stroke care and will help us
to offer a better future for our stroke patients.
We are sure that the warm and kind environment, which you find in the ancient
Mediterranean city of Valencia formed by the successive admixture of many different
cultures devoted to trade, will help you to enjoy your stay with us. Just a few
recommendations: Do not miss its old neighbourhoods, its ancient university, where Cajal
worked for some years at the beginning of his career, its nice gastronomy in which rice
is king, or the new buildings at Ciutat de les Arts i les Ciències due to Santiago Calatrava.
Make yourself at home in Valencia and enjoy the conference.
Jordi Matías-Guiu
Chairman of the Local Organising Committee
2

Committees
Programme Committee
Chairman:
Michael G. Hennerici, Germany
Julien Bogousslavsky, Switzerland
Martin Brown, United Kingdom
José M. Ferro, Portugal
Gian Luigi Lenzi, Italy
Jean-Louis Mas, France
Jorge Matías-Guiu, Spain
Bo Norrving, Sweden
Nils-Gunnar Wahlgren, Sweden
Scientific Committee
Chairman:
J. Bogousslavsky, Switzerland
F. Aichner, Austria
P. Amarenco, France
N.D. Artemis, Greece
R. Baumgartner, Switzerland
S. Blecic, Belgium
N. Bornstein, Israel
M. Brown, United Kingdom
A. Carolei, Italy
L. Csiba, Hungary
A. Czlonkowska, Poland
M. Daffertshofer, Germany
A. Davalos, Spain
S. Davis, Australia
J. De Reuck, Belgium
E. Diez Tejedor, Spain
F. Fazekas, Austria
J.M. Ferro, Portugal
W. Hacke, Germany
G. Hankey, Australia
M.G. Hennerici, Germany
I. Henriques, Portugal
D. Inzitari, Italy
D. Karacostas, Greece
M. Kaste, Finland
P. Koudstaal, The Netherlands
E. Kumral, Turkey
W. Kuschinsky, Germany
G.L. Lenzi, Italy
D. Leys, France
J. Lodder, The Netherlands
H. Markus, United Kingdom
J.L. Marti-Vilalta, Spain
J.L. Mas, France
J. Matías-Guiu, Spain
H. Mattle, Switzerland
J.P. Mohr, USA
B. Norrving, Sweden
J.M. Orgogozo, France
K. Overgaard, Denmark
G. Oezdemir, Turkey
P.M. Rothwell, United Kingdom
D. Russell, Norway
P. Sandercock, United Kingdom
D. Toni, Italy
R. von Kummer, Germany
N.G. Wahlgren, Sweden
S. Warach, USA
C. Warlow, United Kingdom
3

Committees
Local Organising Committee
Chairman:
Jorge Matías-Guiu, Alicante
Co-Chairman:
Exuperio Diez Tejedor, Madrid
Francisco Gracia, Alicante (Secretariat)
José Manuel Moltó, Alicante (Secretariat)
Angel Pérez, Alicante (Secretariat)
José Alvarez-Sabín, Barcelona
José Antonio Egido, Madrid
4
Alberto Gil-Peralta, Sevilla
Aida Lago, Valencia
José Miguel Láinez, Valencia
José Larracoechea, Bilbao
Eduardo Martínez-Vila, Pamplona
Ricardo Navarro, Oviedo
Francisco Rubio, Barcelona
José Villanueva, Madrid
José Vivancos, Madrid

Important Addresses
Congress Palacio de Congresos Phone +34 96 317 94 34
Venue Avda. Cortes Valencianas, 60 Fax +34 96 317 94 35
E-46015 Valencia, Spain
Scientific Prof. Dr. Julien Bogousslavsky Phone +41 21 314 12 30
Committee Département de Neurologie Fax +41 21 314 12 31
Centre Hospitalier Universitaire E-mail julien.bogousslavsky@
Vaudois CHUV
CH-1011 Lausanne, Switzerland
chuv.hospvd.ch
Programme Prof. Dr. Michael G. Hennerici Phone +49 621 383 28 85
Committee Neurologische Universitätsklinik Fax +49 621 383 38 07
Universität Heidelberg E-mail hennerici@neuro.ma.
D-68135 Mannheim, Germany
uni-heidelberg.de
Administrative ESC 2003 Phone +41 61 686 77 11
Secretariat c/o AKM Congress Service Fax +41 61 686 77 88
PO Box E-mail info@akm.ch
CH-4005 Basel, Switzerland
Exhibition AKM Congress Service Phone +41 61 686 77 66
Exhibition Department Fax +41 61 686 77 88
PO Box E-mail exhibition@akm.ch
CH-4005 Basel, Switzerland
Hotel AKM Travel Phone +41 61 690 94 11
Accommodation Messeplatz 10 Fax +41 61 690 94 14
and Tours PO Box E-mail akmtravel@akm.ch
CH-4016 Basel, Switzerland
www.eurostroke.org
5

Programme at a Glance Wednesday, May 21, 2003
07.00
07.30
08.00
08.30
09.00
09.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
14.00
14.30
15.00
15.30
16.00
16.30
17.00
17.30
18.00
18.30
19.00
19.30
6
Auditorium I Auditorium II Committee Rooms
Satellite Symposium
Sanofi-Synthelabo/BMS
Satellite Symposium
Pfizer
Teaching Courses

Thursday, May 22, 2003
Auditorium I Auditorium II Auditorium III
Educational Symposium I
Sanofi-Synthelabo/BMS
Educational Symposium II
NMT Medical
Coffee Break
Stroke in the World Risk Factors of Stroke
Satellite Symposium
Iberoamerican
Cerebrovascular
Disease Society
Lunch and Poster Preview I
Poster Session I
Satellite Symposium
Boehringer Ingelheim
Genetics and Molecular
Markers in Stroke
Dementia and Cognitive
Dysfunction
Satellite Symposium
Grupo Uriach
07.00
07.30
08.00
08.30
09.00
09.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
14.00
14.30
15.00
15.30
16.00
16.30
17.00
17.30
18.00
18.30
19.00
19.30
7

Programme at a Glance Friday, May 23, 2003
07.00
07.30
08.00
08.30
09.00
09.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
14.00
14.30
15.00
15.30
16.00
16.30
17.00
17.30
18.00
18.30
19.00
19.30
8
Auditorium I Auditorium II Auditorium III
Stroke Unit Concepts – Stroke
Monitoring
Acute Stroke
Symptoms and Diagnosis
Acute Stroke
Treatment Concepts
Acute Stroke
Outcome
Introduction Introduction
Diagnosis and Treatment with
Ultrasound
Coffee Break
Venous Diseases
Meta-Analyses and Reviews
Lunch and Poster Preview II
Recovery and
Rehabilitation
Poster Session II
Satellite Symposium
EUSI
Vascular, Interventional
and Neurosurgery
Experimental
Studies
Cardiovascular Topics:
PFO and IMT
Satellite Symposium*
* Cochrane Stroke Group/Stroke Unit Trialists Collaboration/European Stroke Unit Group

Saturday, May 24, 2003
Auditorium I Auditorium II Auditorium III
ICH and SAH
Invited Lecture
Award Presentations
News from Large
Clinical Trials
Closure and Announcement of ESC 2004
Neuroimaging Management and Economics
Coffee Break
07.00
07.30
08.00
08.30
09.00
09.30
10.00
10.30
11.00
11.30
12.00
12.30
13.00
13.30
14.00
14.30
15.00
15.30
16.00
16.30
17.00
17.30
18.00
18.30
19.00
19.30
9

Scientific Programme Wednesday, May 21, 2003
14.00–17.00 Committee Rooms
10
Teaching Course 1: Genetics in Stroke
Chair: H. Markus, United Kingdom
Genetics of monogenic ischaemic stroke including CADASIL
M. Dichgans, Germany
Genetics of polygenic stroke including study design
H. Markus, United Kingdom
The use of intermediate phenotypes in genetic research
R. Schmidt, Austria
Monogenic disorders causing intracranial haemorrhage
J. Haan, The Netherlands
Teaching Course 2: Less Common Causes of Stroke
Chair: S. Blecic, Belgium
Update on dissections
T. Brandt, Germany
Acute vasculitis
S. Blecic, Belgium
Mitochondrial disorders and stroke
A.L. Andreu, Spain
Cerebral amyloid angiopathy and stroke: clinical spectrum
D. Leys, France

Teaching Course 3: Rehabilitation and Recovery
Chair: C. Weiller, Germany
Endogenous and exogenous cell therapy in stroke
J. Winkler, Germany
Imaging issues in stroke recovery
C. Weiller, Germany
CI therapy and affiliates
C. Dettmers, Germany
Early supported discharge – the future of stroke rehabilitation
P. Langhorne, United Kingdom
Teaching Course 4: Specific Diagnostics
Chair: H. Mattle, Switzerland
Ultrasound standard/experienced (2 groups)
H. Mattle, Switzerland and M. Daffertshofer, Germany
Infarct, haemorrhage, tumour or what?
Basics in CT and MRI interpretation. CT/MRI experienced (2 groups)
R. von Kummer, Germany and J. Röther, Germany
Cardiac procedures
C. Seiler, Switzerland
Neuropsychology
J. Ferro, Portugal
11

Scientific Programme Wednesday, May 21, 2003
14.00–17.00 Committee Rooms
12
Teaching Course 5: Multidisciplinary Caring Issues after
Stroke
Chair: M. Walker, United Kingdom
Secondary complications after stroke
B. Indredavik, Norway
Cognitive, emotional and behavioural consequences
of stroke
J. Hochstenbach, The Netherlands
Non-pharmacological approach to depression
N. Lincoln, United Kingdom
Care in the community
M. Walker, United Kingdom

17.00–18.30 Auditorium I
Satellite Symposium sponsored by Sanofi-Synthelabo/BMS:
Exploring New Antiplatelet Strategies in Stroke Prevention
Chairs: W. Hacke, Germany and A. Davalos, Spain
17.00–17.05 Introduction
W. Hacke, Germany and A. Davalos, Spain
17.05–17.25 Role of inflammation in stroke and atherothrombosis
A. Chamorro, Spain
17.25–17.45 Recent clinical trial results with antiplatelet therapy:
implications in stroke prevention
P. Teal, Canada
17.45–18.05 Atrial fibrillation: exploring a new role for antiplatelet
therapy?
S. Connolly, Canada
18.05–18.25 Ongoing trials with antiplatelet therapy in acute and
secondary stroke prevention – setting a new standard
of care?
G. Hankey, Australia
18.25–18.30 Conclusion
W. Hacke, Germany and A. Davalos, Spain
13

Scientific Programme Wednesday, May 21, 2003
17.00–18.30 Auditorium II
14
Satellite Symposium sponsored by Pfizer:
Stroke Prevention and Potential Role of Statins
Chair: J. Bogousslavsky, Switzerland
16.30–17.00 Refreshments
17.00–17.05 Welcome and introduction
J. Bogousslavsky, Switzerland
17.05–17.25 Stroke prevention and lipid lowering: an evolving relationship
M.G. Hennerici, Germany
17.25–17.45 The biological basis for statin therapy in stroke prevention –
anti-atherosclerotic properties
H. Sillesen, Denmark
17.45–18.05 The biological basis for statin therapy in stroke prevention –
neuroprotective properties beyond lipid lowering
R. Paoletti, Italy
18.05–18.25 The Anglo-Scandinavian Cardiac Outcomes Trial ASCOT:
impact of statin therapy on stroke in a hypertensive population
B. Dahlöf, Sweden
18.25–18.30 Summary and close
J. Bogousslavsky, Switzerland

Thursday, May 22, 2003
08.30–10.30 Auditorium I
Educational Symposium sponsored by Sanofi-Synthelabo/BMS:
Imaging: Upcoming Techniques and Implications for
Treatment
Chairs: J. Bogousslavsky, Switzerland and E. Diez Tejedor, Spain
08.30–08.35 Introduction
J. Bogousslavsky, Switzerland and E. Diez Tejedor, Spain
08.35–09.00 The unstable plaque
M.G. Hennerici, Germany
09.00–09.25 Advances in penumbra imaging with MR
S. Davis, Australia
09.25–09.50 Imaging viable brain tissue with CT scan
R. Meuli, Switzerland
09.50–10.15 Towards a new mapping of brain cortex function
R. Frackowiak, United Kingdom
10.15–10.30 Conclusion
J. Bogousslavsky, Switzerland and E. Diez Tejedor, Spain
10.30–11.00 Coffee Break
15

Scientific Programme Thursday, May 22, 2003
11.00–13.00 Auditorium I
16
Oral Session: Stroke in the World
Chairs: J. Matias-Guiu, Spain and G. Hankey, Australia
11.00–11.10 First-ever stroke incidence and stroke sub-type in a predominantly
black population, Barbados, West Indies
D.O.C. Corbin, V. Poddar, A. Hennis, H. Fraser, C. Wolfe, R. Wilks,
Chronic Disease Research Centre, School of Clinical Medicine and Research,
UWI, Barbados
11.10–11.20 Stroke epidemiology in Russia
E.I. Gusev, V.I.Skvortsova, L.V. Stakhovskaya, N.Y. Airian,
Russian State Medical University, Russian Federation
11.20–11.30 First year results of the Third Stroke Registry in Tartu, Estonia
R. Vibo, J. Kõrv, M. Roose, University of Tartu, Estonia
11.30–11.40 Implications of rates of non-fatal acute cerebrovascular versus
coronary vascular events for provision of acute services:
Oxford Vascular Study
C. Coull, L. Silver, P. Rothwell, Stroke Prevention Research Unit,
University of Oxford, United Kingdom
11.40–11.50 A 5-year prospective study of young stroke in China
M. Weiwei Zhang, Z. Zhang, Q. Bi, Y. Wang, W. Ma, China
11.50–12.00 Comparison of worldwide First-ever-in-a-lifetime (FES) stroke
incidence risk: implications for current and future stroke incidence
P. Syme, A. Byrne, R. Chen, A. Finlayson, Borders General Hospital,
University of Edinburgh, United Kingdom
12.00–12.10 The Tintswalo Hospital Stroke Register:
a rural South African stroke register
M. Connor, B. Casserly, M. Thorogood, C. Warlow, SASPI Project Team,
University of the Witwatersrand, South Africa

12.10–12.20 The community-based incidence of stroke in a Scottish population,
the Scottish Borders Stroke Study (SBSS)
P. Syme, A. Byrne, R. Devenny, R. Chen, J. Forbes,
University of Edinburgh, United Kingdom
12.20–12.30 Eligibility for acute stroke therapy in the community:
estimates from North East Melbourne Stroke Incidence Study
(NEMESIS), an Australian population based stroke incidence study
A.K. Gilligan, J.W. Sturm, H.M. Dewey, G.A. Donnan, R.A. Macdonell,
A.G. Thrift, National Stroke Research Institute, Australia
12.30–12.40 LiLAC – Life Long After Cerebral ischemia. Preliminary results on
long-term (>10 years) survival in patients with cerebral ischaemia of
arterial origin
I. van Wijk, A. Algra, LiLAC Study Group, University Medical Centre Utrecht,
The Netherlands
12.40–12.50 The Third Auckland Regional Community Stroke Study: early results
M.L. Hackett, C.S. Anderson, K. Carter, V. Feigin, N. Anderson, A. Barber,
P. Brown, N. Kerse, R. Bonita, ARCOS Collaborative Group,
Clinical Trials Research Unit, Faculty of Medicine and Health Science,
New Zealand
12.50–13.00 Accurate early diagnosis with and without neuroimaging studies
C. Marini, T. Russo, I. Ciancarelli, D. Cerone, M. Baldassarre, A. Carolei,
University of L'Aquila, Italy
17

Scientific Programme Thursday, May 22, 2003
11.00–13.00 Auditorium II
18
Oral Session: Risk Factors of Stroke
Chairs: J.M. Orgogozo, France and P. Sandercock, United Kingdom
11.00–11.10 Predictive value of the combined measurement of IMT, ABI and hsCRP
for the development of new cerebrovascular events:
results of the prospective population-based INVADE trial
D. Sander, U. Scherpinski, H. Bickel, H. Gnahn, B. Conrad,
Technical University of Munich, Germany
11.10–11.20 Risk factors and prognosis of lacunar stroke in a population study
S. Sacco, C. Marini, F. De Santis, M. Baldassarre, L. Olivieri, A. Carolei,
University of L'Aquila, Italy
11.20–11.30 Fasting plasma glucose and risk of incident ischemic stroke and
transient ischemic attacks: A J Shaped Association
D. Tanne, N. Koren-Morag, U. Goldbourt, Sheba Medical Center, Israel
11.30–11.40 C reactive protein predicts further major vascular events in stroke
patients with intracranial atherosclerotic stenoses
J.F. Arenillas, C.A. Molina, P. Chacon, J. Montaner, A. Rovira, A. Penalba,
M. Quintana, J. Alvarez-Sabín, Cerebrovascular Unit, Vall d'Hebron Hospital,
Spain
11.40–11.50 Increased leukocyte-platelet complex formation in acute
symptomatic compared with asymptomatic severe carotid stenosis
D.J.H. McCabe, P. Harrison, I.J. Mackie, P.S. Sidhu, G. Purdy, A.S. Lawrie,
H. Watt, S.J. Machin, M.M. Brown, Stroke Research Unit, Institute of
Neurology, The National Hospital for Neurology & Neurosurgery and
The Haemostasis Research Unit, Department of Haematology,
University College London, United Kingdom
11.50–12.00 Is the association between self-reported stress and stroke modified
by alcohol?
N. Nielsen, J. Barefoot, T. Truelsen, S. Paaske, K. Overvad, P. Schnohr,
M.M. Grønbæk, Alcohol Research, National Institute of Public Health, Denmark

12.00–12.10 Cerebral microbleeds is a risk factor for subsequent intracerebral
hemorrhage among patients with acute ischemic stroke
Y.H. Fan, L. Zhang, V. Mok, W.W. Lam, K.S. Wong, Chinese University of
Hong Kong, Hong Kong
12.10–12.20 Prevalence of aspirin resistance in a population-based study of
patients with acute vascular events: Oxford Vascular Study (OXVASC)
L. Silver, A. Coull, P. Harrison, H. Segal, P. Rothwell,
Stroke Prevention Research Unit, University of Oxford, United Kingdom
12.20–12.30 Protein Z in ischaemic stroke and its aetiological subtypes
G. Hankey, A. McQuillan, J. Eikelboom, R. Baker, J. Thom, J. Staton, Q. Yi,
V. Cole, Royal Perth Hospital, Australia
12.30–12.40 Peripheral arterial disease in Asian stroke patients: frequency,
risk factors and association with stroke sub-type
R. Esagunde, C.F. Chan, H.B. Pey, H.H. Tey, A. Auchus, H.M. Chang,
M.C. Wong, C. Chen, National Neuroscience Institute,
Singapore General Hospital Campus, Singapore
12.40–12.50 Brain arteriovenous malformations: age-dependent clinical and
morphologic characteristics in a prospective patient cohort
C. Stapf, A.V. Khaw, H.C. Schumacher, R.R. Sciacca, A. Hartmann, H. Mast,
J.P. Mohr, Columbia University College of Physicians & Surgeons, USA
12.50–13.00 Ischemic tolerance biochemical factor in transitory ischemic attack
patients
M. Blanco, R. Leira, I. Lizasoain, M.A. Moro, A. Davalos, J. Castillo,
Hospital Clínico Universitario de Santiago de Compostela, Spain
19

Scientific Programme Thursday, May 22, 2003
11.00–12.00 Auditorium III
20
Oral Session: Genetics and Molecular Markers in Stroke
Chairs: M. Dichgans, Germany and H. Markus, United Kingdom
11.00–11.10 Angiotensin converting enzyme: the DD genotype is associated with
carotid artery stenosis in non-diabetic men
U. Schminke, J. Luedemann, A. Kilian, F. Herrmann, U. John, C. Kessler,
Ernst-Moritz-Arndt University, Germany
11.10–11.20 TNF-alpha G-308A gene polymorphism and the clinical course
of cerebral infarction
G. Gromadzka, M. Baranska, A. Ciesielska, T. Mendel, I. Sarzynska-Dlugosz,
A. Czlonkowska, Institute of Psychiatry and Neurology, Poland
11.20–11.30 Pro-inflammatory gene-load is associated with enhanced
inflammation and early carotid artery atherosclerosis in smokers
P. Jerrard-Dunne, M. Sitzer, P. Risley, A. Buehler, S. von Kegler, H.S. Markus,
St. George’s Hospital Medical School, United Kingdom
11.30–11.40 Polymorphisms of the angiotensin converting enzyme,
angiotensinogen and endothelial nitric oxide synthase genes in the
carotid atherothrombotic stroke
S.A. Limborska, E.A. Roltsova, P.A. Slominsky, I.M. Shetova, T.I. Tupitsina,
V.I. Skvortsova, Russian State Medical University, Institute of Molecular
Genetics, Russian Federation
11.40–11.50 Headache in intracerebral hemorrhages is associated with molecular
markers for inflammation and predicts the volume of the residual lesion
R. Leira, Y. Silva, J. Tejada, A. Gil, E. Mostacero, J. Castillo, Proyecto Ictus del
GEECV de la SEN, Spain
11.50–12.00 Evidence of publication bias in genetic epidemiology:
a systematic review
E. Flossmann, U.G. Schulz, P.M. Rothwell, Stroke Prevention Research Unit,
Radcliffe Infirmary, University of Oxford, United Kingdom

12.00–13.00 Auditorium III
Oral Session: Dementia / Higher Cognitive Dysfunction
Chairs: G.L. Lenzi, Italy and D. Leys, France
12.00–12.10 Predicting dementia in patients with cerebrovascular disease:
results from PROGRESS
Y. Ratnasabapathy, C.A. Anderson, C. Tzourio, M. Jones, PROGRESS
(Perindopril Protection against Recurrent Stroke Study) Collaborative Group,
Clinical Trials Research Unit, University of Auckland and Institute of
International Health, University of Sydney, New Zealand and Australia
12.10–12.20 Long-term neuropsychological dysfunction in young adults with
stroke. A case-control study
C. Jacas, N. Lopez, R. Galisteo, M. Ribo, J.F. Arenillas, C. Molina, M. Vilardell,
J. Alvarez-Sabín, Vall d'Hebron General Hospital, Spain
12.20–12.30 Age-related white matter changes as a predictor of disability in the
elderly: the LADIS (Leukoaraiosis and disability) project
D. Inzitari, LADIS Study Group, Department of Neurological and Psychiatric
Sciences, University of Florence, Italy
12.30–12.40 Neuropsychological correlates of leukoaraiosis in patients with
dementia
P. Sucapane, F. Bologna, L. Fiorelli, S. Mearelli, C. Marini, A. Carolei,
University of L'Aquila, Italy
12.40–12.50 How useful are simple outcome measures for detecting dementia in
large-scale clinical trials? Experience from the PROGRESS trial
Y. Ratnasabapathy, C.A. Anderson, C. Tzourio, M. Jones, PROGRESS
(Perindopril Protection against Recurrent Stroke Study) Collaborative Group,
Clinical Trials Research Unit, University of Auckland, New Zealand
12.50–13.00 Discussion
13.00–14.30 Lunch and Poster Preview I
(see pages 54–78)
21

Scientific Programme Thursday, May 22, 2003
14.30–16.00 Auditorium I
22
Joint Meeting on PFO Closure between the European Stroke
Conference and Euro-PCR
with direct satellite transmission between Paris and Valencia and live case
demonstration from Rotterdam
A Meeting of Hearts and Minds
Bringing Closure to Cardiac Sources of Stroke
Chair (Valencia): M.G. Hennerici, Germany
Panelists: J. Bogousslavsky, Switzerland, P. Kramer, USA and H.P. Adams, USA
Chair (Paris): H. Sievert, Germany
Panelists: I. Palacios, USA, E. Eeckhout, Switzerland, N. Futrell, USA and
M. Landzberg, USA
14.30–14.50 Introduction – Scope of the problem
J. Bogousslavsky, Switzerland
A prescription a day keeps the implant away – Arguments for
and against medical therapy vs. PFO closure and the utility of a patient
registry, euroPFOre
M.G. Hennerici, Germany
Make me whole, fix my heart, change my life – Acute and follow-up
results in > 500 PFO closure patients
H. Sievert, Germany
14.50–15.20 Live PFO closure case transmission: Thoraxcenter Rotterdam
(The Netherlands)
P. Koudstaal, P. Serruys, M. Witsenburg, F. Meijboom, The Netherlands
15.20–15.30 Marriage of hearts and minds – how to organise a PFO programme
Neurologist’s view – patient selection
N. Futrell, USA
Cardiologist’s view – treatment management
P. Kramer, USA

15.30–15.50 Questions from Paris and Valencia panels and audiences
Current recommendations, practices and future perspectives for
patient management
First randomised controlled trials
H.P. Adams, USA
Concluding remarks
16.00–17.30 Poster Session I
Chairs: S. Davis, Australia, W. Hacke, Germany and J. Ferro, Portugal
(see pages 54–78)
17.30–19.00 Auditorium I
3 rd Academic Symposium of the Iberoamerican Cerebrovascular
Diseases Society:
Ischemic Stroke. New Approaches and Opportunities
Chairs: J. Matías-Guiu, Spain and G. Saposnik, Argentina
17.30–17.35 Introduction: Ischemic stroke. Rethinking the therapeutic opportunities
G. Saposnik, Argentina
17.35–17.50 Emerging stroke risk factors and the role of inflammation.
Can it be modified?
O. del Bruto, Ecuador
17.50–18.05 Anticoagulant and antiplatelet drugs in ischemic stroke prevention.
Are they adequately used? Should they be reconsidered?
O. Benavente, USA
18.05–18.20 Reperfusion therapies in acute ischemic stroke.
Experience in Iberoamerica. Fancies and fantasies.
A. Massaro, Brazil
23

Scientific Programme Thursday, May 22, 2003
17.30–19.00 Auditorium I
18.20–18.35 From homeostasis to neuroprotection in acute ischemic stroke.
Opportunity to an early intervention
E. Díez Tejedor, Spain
18.35–18.50 Vascular cognitive impairment. Can it be prevented and treated?
V. Hachinski, Canada
18.50–19.00 Discussion
Closing remarks
J. Matías-Guiu, Spain
24
Organised by the Iberoamerican Cerebrovascular Diseases Society with the
help of the European Stroke Council. All participants have been invited by
the Iberoamerican Cerebrovascular Diseases Society. Partially sponsored by
Ferrer Group with a non-restrictive grant.

17.30–19.00 Auditorium II
Satellite Symposium sponsored by Boehringer Ingelheim:
Modern Stroke Management – Redefining Therapeutic
Options? From Acute Treatment to the PRoFESS Trial
Chairs: G. Albers, USA and W. Hacke, Germany
17.30–17.40 Introduction
W. Hacke, Germany
17.40–17.55 Departing into a new future of stroke therapy
W. Hacke, Germany
17.55–18.10 SITS-MOST (PMS study for rt-PA across Europe)
N.G. Wahlgren, Sweden
18.10–18.25 Combination antiplatelet therapy: do the risks/benefits differ
for stroke vs. MI?
G. Albers, USA
18.25–18.40 The cerebrovascular connection to cardiovascular risk –
the role of ARBs
A. Coca, Spain
18.40–18.55 Prevention Regimen of Effectively avoiding Second Strokes.
The PRoFESS Trial
H.C. Diener, Germany and R. Sacco, USA
18.55–19.00 Concluding remarks
G. Albers, USA and W. Hacke, Germany
25

Scientific Programme Thursday, May 22, 2003
17.30–19.00 Auditorium III
17.00–17.35 Welcome
26
Satellite Symposium sponsored by Grupo Uriach:
New Challenges of the Antithrombotic Treatment
Chairs: M.D. Jiménez, Spain and I.L. Henriques, Portugal
17.35–17.55 Contribution of Triflusal to secondary stroke prevention after TAPIRSS
and TACIP studies
J. Ferro, Portugal
17.55–18.15 Counteraction of antihypertensive drugs effects by aspirin.
Is the debate still going on?
J. Redón, Spain
18.15–18.35 Safety of antithrombotic drugs: an update
A. Culebras, USA
18.35–18.55 Stroke and dementia: new findings and future perspectives
D. Muñoz, Spain
18.55–19.00 Round table discussion

Friday, May 23, 2003
08.00–08.30 Auditorium II
Introduction European Society of Neurosonology and
Cerebral Hemodynamics 2003
E.B. Ringelstein, Germany
08.00–08.30 Auditorium III
Introduction Early Surgery Trialists
W. Sandmann, Germany
08.30–10.00 Auditorium I
Oral Session: Stroke Unit Concepts – Stroke Monitoring
Chairs: A. Davalos, Spain and D. Toni, Italy
08.30–08.40 Adjusting favourable outcomes following treatment of acute ischemic
stroke as influenced by baseline severity of neurological impairments
H. Adams, W. Hacke, A. Blumki, W. Clarke, M.D. Hansen, J. LeClerc,
University of Iowa, USA
08.40–08.50 Implementing acute stroke unit care: from clinical trial to clinical
practice
P. Langhorne, F. Wright, M. Shields, G. MacIntosh, D.J. Stott, Academic
Section of Geriatric Medicine, University of Glasgow, United Kingdom
08.50–09.00 Improved ADL performance after stroke unit care.
Results from the Swedish national registry for quality assessment
of acute stroke care
A.B. Stegmayr, K. Asplund, E.L. Glader, K. Hulter-Åsberg, B. Norrving,
A. Terént, P.O. Wester, Department of Public Health and Clinical Medicine,
Sweden
27

Scientific Programme Friday, May 23, 2003
08.30–10.00 Auditorium I
09.00–09.10 All patients with acute stroke should have access to stroke unit care.
How to reach this goal?
L. Candelise, G. Micieli, R. Sterzi, PROSIT, IRCCS Ospedale Maggiore
Policlinico, Italy
09.10–09.20 Effect of implementing stroke units in an area-wide concept on stroke
care. The Baden-Württemberg Study
M. Daffertshofer, M. Felsenstein, V. Schuchhardt, M.G. Hennerici, University
Heidelberg, Universitätsklinikum Mannheim, Germany
09.20–09.30 Teleneurology to improve stroke care in rural areas – final results
from the TESS project
A. Wiborg, B. Widder, Bezirkskrankenhaus Guenzburg, Germany
09.30–09.40 Variation in the management of acute physiological parameters after
ischaemic stroke: a European perspective
A. Bhalla, T. Mendel, P. Kolominsky-Rabas, P. Heuschmann, S. Eddine
Megherbi, A. Czlonkowska, A. Kobayashi, M. Giroud, A. Rudd, C. Wolfe,
Public Health Department, Guy's, King's and St Thomas' School of Medicine,
United Kingdom
09.40–09.50 The prognostic impact of arrhythmias and atrioventricular block in
acute stroke
A.H. Christensen, A.F. Christensen, G. Boysen, Bispebjerg Hospital, Denmark
09.50–10.00 Impairment of respiratory muscle function in acute stroke patients
F. Harraf, W.D. Man, G.F. Rafferty, M.I. Polkey, J. Moxham, L. Kalra, Guy's,
King's and St Thomas' School of Medicine, King's College London,
United Kingdom
28

08.30–10.00 Auditorium II
Oral Session: Diagnosis and Treatment with Ultrasound
Chairs: N. Bornstein, Israel and D. Russell, Norway
08.30–08.40 What is the nature and clinical importance of microembolic signals in
carotid endarterectomy?
T. Karapanayiotides, P. Ruchat, G. Darbellay, V. Kemeny, B. Piechowski-
Jozwiak, J.M. Vesin, P.A. Despland, J. Bogousslavsky, G. Devuyst,
Centre Hospitalier Universitaire Vaudois and EPFL, Switzerland
08.40–08.50 Correlation of atherosclerotic changes between carotid, coronary and
femoral arteries. Comparison of in vivo findings with autopsy
L. Kerenyi, S. Molnar, M. Ritter, T. Magyar, E.B. Ringelstein, L. Csiba,
University of Debrecen, Medical and Health Science Center, Hungary
08.50–09.00 To what extent is pathological correlation in studies of imaging of
carotid plaque compromised by unreliability of the histological
assessment?
J. Lovett, P. Gallagher, P. Rothwell, Stroke Prevention Research Unit,
University Department of Clinical Neurology, Radcliffe Infirmary,
United Kingdom
09.00–09.10 Intracranial stenosis in ischemic stroke: no relation with traditional
atherosclerotic risk factors
I. Henriques, I. Mendes, S. Mateus, S. Pires-Barata, L. Rebocho,
Hospital Espirito Santo, Portugal
09.10–09.20 Ultrasonic long-term follow-up of asymptomatic atherosclerotic
stenosis of the middle cerebral artery
C. Kremer, T. Schättin, R.W. Baumgartner, University Hospital Zürich,
Switzerland
09.20–09.30 Acceleration of MCA recanalisation by transcranial ultrasound:
a therapeutic option for patients not eligible for thrombolysis?
J. Eggers, B. Koch, K. Meyer-Wiethe, University Hospital Lübeck, Germany
29

Scientific Programme Friday, May 23, 2003
08.30–10.00 Auditorium II
09.30–09.40 Safety and efficacy of thrombotripsy – acceleration of thrombolysis by
TCCS
M. Bar, D. Skoloudik, P. Hradilek, D. Vaclavik, O. Skoda, Faculty Hospital
Ostrava-Poruba, Czech Republic
09.40–09.50 Characterisation of brain perfusion in acute stroke using flash
destruction imaging with real-time power-pulse inversion ultrasound –
a comparison with perfusion-weighted MRI
R. Kern, F. Perren, A. Gass, M.G. Hennerici, S. Meairs, University of
Heidelberg, Universitätsklinikum Mannheim, Germany
09.50–10.00 Quantitative assessment of cerebral blood flow with real-time power
pulse inversion contrast harmonic imaging
S. Meairs, P. Horn, K. Schöneberger, R. Kern, F. Perren, M. Fatar, M.G. Hennerici,
University of Heidelberg, Universitätsklinikum Mannheim, Germany
08.30–10.00 Auditorium III
30
Oral Session: Vascular, Interventional and Neurosurgery
Chairs: M. Brown, United Kingdom and H. Mattle, Switzerland
08.30–08.40 A systematic review of the risks of carotid endarterectomy in
relation to the clinical indication and the timing of surgery
R. Bond, K. Rerkasem, P.M. Rothwell, Stroke Prevention Research Unit,
Radcliffe Infirmary, United Kingdom
08.40–08.50 The acute and long-term results of carotid angioplasty
K. Rabe, H. Goedel, R. Perron, I. Boesenberg, K.F. Beykirch, R. Theis,
C. Rubel, W. Pfeil, H. Sievert, Cardiovascular Center Bethanien, Germany
08.50–09.00 Spanish registry of carotid angioplasty and stenting. Preliminary report
J. Vivancos-Mora, A. Gil-Nuñez, A. Gil-Peralta, D. Escuder-Rubi, J. Matias-Guiu,
J.R. Gonzalez-Marcos, R. Gonzalez-Santiago, F. Villoria-Medina,
J. Sanchez-Ojanguren, J. Morera-Guitart, Stroke Project of the
Cerebrovascular Study Group of the Spanish Neurological Society,
Stroke Unit, Hospital Universitario de la Princesa, Spain

09.00–09.10 Endovascular stent-assisted angioplasty for symptomatic intracranial
vertebrobasilar artery stenosis and dissection
T.H. Lee, D.H. Kim, B.H. Lee, H.J. Kim, S.H. Lee, D.S. Jung, Pusna National
University Hospital, South Korea
09.10–09.20 Endovascular stent-assisted angioplasty for symptomatic middle
cerebral artery stenosis: feasibility and complication
T.H. Lee, D.H. Kim, B.H. Lee, H.J. Kim, S.H. Lee, D.S. Jung, Pusan National
University Hospital, South Korea
09.20–09.30 Clinical presentation and surgical revascularisation procedures in
Moyamoya disease and syndrome in Europe
N. Khan, B. Schuknecht, A. Buck, E. Boltshauser, H.G. Imhof, Y. Yonekawa,
University Hospital Zürich, Switzerland
09.30–09.40 Stereotactic aspiration of deep intracerebral hematomas under
computed tomographic control. A multicentric prospective
randomised trial
H. Hosseini, C. Leguerinel, M. Hariz, E. Melon, S. Palfi, P. Deck, A. Gaston,
P. Cesaro, J.P. Nguyen, Chu Henri Mondor, France
09.40–09.50 Ischaemic stroke due to the acute internal carotid artery occlusion:
results of the emergent carotid disobliteration versus conservative
treatment
R. Herzig, M. Bar, I. Vlachova, B. Krupka, D. Sanak, P. Bachleda, P. Utikal,
J. Machac, S. Burval, J. Mares, Stroke Center, Olomouc and Clinic of
Neurology, Czech Republic
09.50–10.00 Prevention of neurological complications during carotid angioplasty
with reversal of flow
K. Rabe, H. Goedel, R. Perron, I. Boesenberg, K.F. Beykirch, R. Theis, C. Rubel,
W. Pfeil, H. Sievert, Cardiovascular Center Bethanien, Germany
10.00–10.30 Coffee Break
31

Scientific Programme Friday, May 23, 2003
10.30–11.30 Auditorium I
32
Oral Session:
Acute Stroke – Symptoms and Clinical Diagnosis
Chairs: L. Caplan, USA and B. Norrving, Sweden
10.30–10.40 Comparison of clinical classification and diffusion-weighted MRI for
acute stroke localisation
K. Murray, C. Santosh, I. Bone, K. Muir, Institute of Neurological Sciences,
Southern General Hospital, United Kingdom
10.40–10.50 DWI signal intensities are different in TIA as compared to stroke
K. Winbeck, K. Bruckmaier, T. Etgen, K. Forster, B. Conrad, D. Sander,
Technical University of Munich, Germany
10.50–11.00 A simple three item stroke score: comparison with the NIHSS score
and prediction of vessel occlusion
O.C. Singer, R.D. Mesnil de Rochemont, H. Lanfermann, C. Foerch, M. Sitzer,
T. Neumann-Haefelin, J.W. Goethe University, Germany
11.00–11.10 Clinical characteristics of transient neurologic deficits of chronic
subdural haematoma
H.G. Sunku, Hinchingbrooke Hospital, United Kingdom
11.10–11.20 Cognitive and behavioural aspects affecting early referral of acute
stroke patients; Bystander’s knowledge of signs and symptoms of
stroke
M. Shah, K. Makinde, D. Schelewa, P. Thomas, Prince Philip Hospital,
United Kingdom
11.20–11.30 Telemedicine for stroke management – feasibility and first
experience using multimedia systems in an acute care setting
R. Handschu, B. Tomandl, R.R. Littmann, J.G. Heckmann,
B. Neundörfer, M. Scibor, University of Erlangen, Germany

10.30–11.30 Auditorium II
Oral Session: Venous Diseases
Chairs: M.G. Bousser, France and A. Czlonkowska, Poland
10.30–10.40 Is smoking a risk factor for cerebral vein and dural sinus thrombosis
in oral contraceptive users? A case control study
A. Ciccone, A. Gatti, C. Coppola, S. Iurlaro, E. Agostani, G. Boncoraglio,
Stroke Unit Azienda Ospedaliera Niguarda Ca' Granda, Italy
10.40–10.50 Jugular valve incompetence in transient global amnesia –
an epiphenomenon?
S.J. Schreiber, F. Doepp, R. Klingebiel, J.M. Valdueza, University Hospital
Charité, Germany
10.50–11.00 Neurological worsening in the acute phase of cerebral venous
thrombosis in ISCVT (International Study on Cerebral Venous
Thrombosis)
I. Crassard, P. Canhão, J.M. Ferro, M.G. Bousser, F. Barinagarrementeria,
J. Stam, ISCVT, Hospital Santa Maria, Portugal
11.00–11.10 Clinical outcome and screening of prothrombotic factors in cerebral
venous thrombosis
L. Derex, S. Cakmak, M. Berruyer, N. Nighoghossian, F. Philippeau,
P. Adeleine, M. Hermier, J.C. Froment, P. Trouillas, Hôpital Neurologique, France
11.10–11.20 Neurological and cognitive long-term outcome of cerebral venous
sinus thrombosis in childhood: report of three cases
G. Buccino, G. Cossu, A. De Fanti, I. Patteri, G.C. Izzi, D. Mancia,
University of Parma, Italy
11.20–11.30 The long-term prognosis of cerebral vein and dural sinus thrombosis:
ISCVT results
J.M. Ferro, J. Stam, M.G. Bousser, F. Barinagarrementeria, P. Canhão, ISCVT,
Hospital Santa Maria, Portugal
33

Scientific Programme Friday, May 23, 2003
10.30–12.30 Auditorium III
34
Oral Session: Experimental Studies
Chairs: L. Hirt, Switzerland and K. Overgaard, Denmark
10.30–10.40 Ischemia of the external carotid artery territory influences outcome in
the endovascular filament model of middle cerebral artery occlusion
in the rat
M. Dittmar, T. Spruss, G. Schuierer, G.W. Ickenstein, M. Horn, Department of
Neurology, University of Regensburg, Germany
10.40–10.50 Hyperbaric Oxygenation (HBO) converts neuronal cell death from
necrosis to apoptosis in transient focal cerebral ischemia in the
infarct core in rats
C.C. Eschenfelder, M. Lou, T. Herdegen, G. Deuschl, Christian-Albrechts
University, Germany
10.50–11.00 Evolving relations between cerebral blood flow and oxygen
metabolism after middle cerebral artery occlusion in the porcine
chronic stroke model
H. Watanabe, A. Olsen, C. Bjarkam, A. Rodell, D. Zeilder, A. Blankholm,
L. Ostergaard, P. Coming, A. Gjedde, Center of Functionally Integrative
Neuroscience, Aarhus University, Denmark
11.00–11.10 Stabilisation of cellular proliferation into steady state over the
arterial filtration struts of the diverter – a novel device for stroke
prevention
D. Tanne, O. Yodfat, D. Harris, Y. Assaf, J. Leor, D. Bushi, Y. Grad,
MindGuard Medical Devices, Israel
11.10–11.20 Celecoxib induces functional recovery after intracerebral
hemorrhage with reduction of brain edema and perihematomal
cell death
K. Chu, K.H. Jung, S.W. Jeong, M. Kim, J.K. Roh, Seoul National University
Hospital, South Korea

11.20–11.30 Hypothalamic injury and subsequent hyperthermia confounds
neuroprotective drugs studies – a comparison between the suture
and the macrosphere MCAO technique
T. Gerriets, E. Stolz, M. Walberer, G. Bachmann, M. Fisher, M. Kaps,
University Giessen, Germany
11.30–11.40 Cortical expression of proinflammatory cytokines in different
preconditioning paradigms in focal brain ischemia
J. Pera, M. Zawadzka, B. Kaminska-Kaczmarek, A. Szczudlik,
Jagiellonian University, Poland
11.40–11.50 Effective emboli diversion by a novel permanent device for prevention
of embolic stroke
Y. Asaff, J. Schneiderman, D. Bushi, J. Leor, D. Harris, B. Nishri, O. Oz,
D. Tanne, Y. Grad, MindGuard Medical Devices, Israel
11.50–12.00 Natural time course of brain edema in the hyperacute phase of
experimental stroke – MRI studies with an in-bore MCA occlusion
technique in rats
T. Gerriets, E. Stolz, M. Walberer, C. Mueller, A. Kluge, A. Bachmann, M. Kaps,
G. Bachmann, University Giessen and Kerckhoff Clinic Bad Nauheim, Germany
12.00–12.10 Minocycline reduces infarct size and rate of hemorrhagic
transformations in SOD2-KO mice
C. Maier, L. Hsieh, F. Yu, P. Chan, Stanford University, USA
12.10–12.20 Determination of the hypothermic component in neuroprotection by
cannabinoids in experimental stroke
P.K. Bonfils, J. Reith, L. Thatt, F.F. Johansen, University of Copenhagen,
Molecular Neuropathology Group, Denmark
12.20–12.30 Short and long-term effects of brief transient middle cerebral artery
occlusion (MCA-o) on gait and working memory in the Wistar rat
C. Sarti, L. Bartolini, D. Inzitari, L. Pantoni, Department of Neurological and
Psychiatric Sciences, University of Florence, Italy
35

Scientific Programme Friday, May 23, 2003
11.30–12.30 Auditorium I
36
Oral Session: Acute Stroke – Treatment Concepts
Chairs: F. Aichner, Austria and M. Kaste, Finland
11.30–11.40 The usefulness of clinical DWI mismatch in the treatment of acute
ischemic stroke with reperfusion therapies
A. Dávalos, R. Leira, S. Pedraza, M. Blanco, J. Serena, Y. Silva,
M. Castellanos, J. Castillo, Hospital Universitari Doctor Josep Trueta, Spain
11.40–11.50 Clinical and radiological predictors of recanalisation and outcome
in 40 patients with acute basilar artery occlusion treated with
intra-arterial thrombolysis
M. Arnold, K. Nedeltchev, R.W. Baumgartner, L. Remonda, G. Schroth,
T.J. Loher, F. Stepper, M. Sturzenegger, H.P. Mattle, University of Berne,
Switzerland
11.50–12.00 Thrombin-activable fibrinolysis inhibitor (TAFI) level is related to
t-PA-induced recanalisation resistance after ischemic stroke
J. Montaner, J. Monasterio, C.A. Molina, M. Ribó, J.F. Arenillas, F. Pujadas,
J. Alvarez-Sabín, Neurovascular Research Laboratory, Stroke Unit,
Vall d'Hebron Hospital, Spain
12.00–12.10 Degree of tPA-induced proximal MCA recanalisation differs among
stroke subtypes
C.A. Molina, E. Santamarina, J. Montaner, J.F. Arenillas, M. Ribo, R. Huertas,
J. Mauriño, J. Alvarez-Sabin, Hospital Vall d'Hebron, Spain
12.10–12.20 Beyond the three hour time-window: multivariable patient-selection
for thrombolytic therapy in acute ischemic stroke
D. Kent, R. Ruthazer, E. Bluhmki, H. Selker, Division of Clinical Care Research,
Tufts New England Medical Center, USA
12.20–12.30 Improved disability endpoint selection for use in acute stroke trials
F.B. Young, K.R. Lees, C.J. Weir, University of Glasgow, United Kingdom

11.30–12.30 Auditorium II
Oral Session: Meta-Analysis and Review Papers
Chairs: G. Donnan, Australia and C. Warlow, United Kingdom
11.30–11.40 High morbidity and mortality due to endarterectomy for asymptomatic
carotid stenosis
R. Bond, K. Rerkasem, P.M. Rothwell, Stroke Prevention Research Unit,
Radcliffe Infirmary, United Kingdom
11.40–11.50 Antithrombotic drugs for carotid artery dissection – a Cochrane
review (update)
A.P. Lyrer, S. Engelter, University Hospital Basel, Neurological Clinic and
Stroke Unit, Switzerland
11.50–12.00 Risk factors for intracerebral hemorrhage in the general population,
a systematic review
M.J. Ariesen, S.P. Claus, G.J.E. Rinkel, A. Algra, University Medical Centre
Utrecht, The Netherlands
12.00–12.10 Antiplatelet therapy for preventing stroke after carotid
endarterectomy – a Cochrane review
S. Engelter, P. Lyrer, University Hospital Basel,
Neurological Clinic and Stroke Unit, Switzerland
12.10–12.20 The Cochrane Library: a useful resource for informing evidence-based
stroke care
P. Sandercock, H. Fraser, B. Thomas, A. McInnes, S. Dixon, The Cochrane
Stroke Review Group, University of Edinburgh, United Kingdom
12.20–12.30 Systematic review of nitric oxide donors and L-arginine in
experimental stroke: effects on infarct size and cerebral blood flow
M. Willmot, S. Murphy, J. Leonardi-Bee, P. Bath, Institute of Neurosciences,
University of Nottingham, United Kingdom
12.30–14.00 Lunch and Poster Preview II
(see pages 79–105)
37

Scientific Programme Friday, May 23, 2003
14.00–16.00 Auditorium I
38
Oral Session: Acute Stroke Outcome
Chairs: M. Daffertshofer, Germany and P. Koudstaal, The Netherlands
14.00–14.10 Safe Implementation of Thrombolysis in Stroke (SITS) – results from
the first two years of an Internet-based register of thrombolysis in
stroke
N. Wahlgren, A. Davalos, C. Fieschi, M. Grond, W. Hacke, M. Kaste, V. Larrue,
K.R. Lees, Karolinska Hospital, Sweden
14.10–14.20 Blood pressure course during the acute phase of stroke is strongly
associated with stroke outcome: tertiary analysis of GAIN International
F. Fazekas, S. Aslanyan, C.J. Weir, S. Horner, K.R. Lees, GAIN International
Steering Committee and Investigators, Karl-Franzens University Graz, Austria
14.20–14.30 Predictictive role of 24-hour blood pressure values on stroke mortality
G. Tsivgoulis, A. Synetos, K. Spengos, E. Manios, V. Kotsis, E. Vassiliadi,
K. Vemmos, University of Athens, Medical School, Greece
14.30–14.40 Clinical symptoms and early outcome in MR-DWI characterised
isolated cerebellar infarction
E. Grips, O. Sedlaczek, M. Fritzinger, M. Daffertshoffer, M.G. Hennerici,
Dept. of Neurology Mannheim, University of Heidelberg, Germany
14.40–14.50 Vertebral artery stenosis: a surprisingly benign condition
L. Coward, M. Brown, Stroke Research Group, Institute of Neurology,
University College London, United Kingdom
14.50–15.00 Long-term follow-up in patients with acute spinal cord infarction
syndrome (ASCIS)
K. Nedeltchev, M. Arnold, H.P. Mattle, T.J. Loher, F. Stepper, M. Sturzenegger,
University of Bern, Switzerland

15.00–15.10 Risk of cerebrovascular and cardiac mortality after major stroke or
minor/lacunar stroke: a review of community-based, follow-up
studies in Europe
F. Guillot, Sanofi-Synthelabo Recherche, France
15.10–15.20 Predictors for in-hospital-mortality after ischemic stroke in routine
clinical practice. The German Stroke Registers Study Group
P.U. Heuschmann, P.L. Kolominsky-Rabas, B. Misselwitz, C. Leffmann,
P. Hermanek, K. Berger, German Stroke Registers Study Group,
Institute of Epidemiology and Social Medicine, Germany
15.20–15.30 Long-term prognosis of patients with a complete MCA territory
infarction treated with decompressive hemicraniectomy
P. Erban, C. Woertgen, R. Luerding, G. Ickenstein, U. Bogdahn, M. Horn,
Departments of Neurology and Neurosurgery, University of Regensburg, Germany
15.30–15.40 What determines quality of life long-term after stroke?
M. Patel, K. Tilling, C. McKevitt, A.G. Rudd, C.D.Wolfe, Dept. of Public Health
Sciences, GKT School of Medicine, King's College London, United Kingdom
15.40–15.50 Long-term evolution of young patients (pts) with stroke:
individualisation of a high risk population
A.A. De Windt, S.M. Jeangette, M. Pandolfo, S.A. Blecic, Erasme Hospital,
Belgium
15.50–16.00 Predictors of disabling fatigue in “non-disabling” stroke
F. Staub, J.M. Annoni, S. Gramigna, J. Bogousslavsky, Centre Hospitalier
Universitaire Vaudois, Switzerland
39

Scientific Programme Friday, May 23, 2003
14.00–16.00 Auditorium II
40
Oral Session: Recovery and Rehabilitation
Chairs: A. Carolei, Italy and P. Langhorne, United Kingdom
14.00–14.10 Intensive early physiotherapy combined with dexamphetamine
treatment in severe stroke. A randomised controlled study
L. Martinsson, S. Eksborg, N.G. Wahlgren, Clinical Neurosciences,
Karolinska Institute, Sweden
14.10–14.20 Life after stroke: multicentre trial of psychosocial interventions after
stroke
M. Leathley, S. Fall, A. Sharma, C. Watkins, D. Barer, University of Central
Lancashire, United Kingdom
14.20–14.30 A randomised trial to evaluate improved routine communication to
patients and carers after stroke
J.E. Smith, A. Forster, J.B. Young, Bradford Elderly Care and Rehabilitation
Research Department (BECARRD), St Luke's Hospital, United Kingdom
14.30–14.40 A family support organiser for stroke patients and their carers:
intervention design and results of a randomised controlled trial
K. Tilling, C. McKevitt, C. Coshall, K. Daneski, C. Wolfe, Department of
Public Health Sciences, King's College London, United Kingdom
14.40–14.50 Serial investigation of neuronal reorganisation in acute stroke
patients using fMRI and DTI techniques
F. Zelaya, V. Ng, A. Evans, M. Brammer, C. Andrew, D. Jones, D. Lythgoe,
J. Grey, S. Williams, L. Kalra, Guy's, King's & St Thomas' School of Medicine,
King's College, United Kingdom
14.50–15.00 Correspondence of therapy-induced changes observed in fMRI and
movement-related cortical potentials in chronic stroke subjects;
preliminary data
A.I.M. Tarkka, M. Könönen, E. Mervaala, K. Pitkänen, J. Sivenius, Brain
Research and Rehabilitation Center, Neuron and Kuopio University Hospital,
Finland

15.00–15.10 The relationship between motor related brain activations and
recovery after stroke: a cross sectional fMRI study
N.S. Ward, M.M. Brown, A.J. Thompson, R.S. Frackowiak, Wellcome
Department of Imaging Neuroscience, Institute of Neurology, United Kingdom
15.10–15.20 The impact of right cerebral hemisphere damage on the use of
gesture and prosody for communication
N. Cocks, K. Hird, K. Kirsner, Curtin University of Technology, Australia
15.20–15.30 Constraint-induced movement therapy for chronic stroke patients
K. Pitkänen, I.M. Tarkka, J. Sivenius, Brain Research and Rehabilitation Center
Neuron, Finland
15.30–15.40 Effect of age on access to stroke care in England, Wales and Northern
Ireland: results from the National Sentinel Audits of Stroke 1998–2002
A.G. Rudd, A. Hoffman, D. Lowe, P. Irwin, M. Pearson, Royal College of
Physicians London, United Kingdom
15.40–15.50 Amphetamine or physical therapy promote rehabilitation in a rat
embolic stroke model
R.S. Rasmussen, K. Overgaard, E.S. Hildebrandt-Eriksen, G. Boysen,
Neurovascular Research Laboratory, Copenhagen University Hospital,
Denmark
15.50–16.00 Intrathecal baclofen – a valid option in rehabilitation of stroke
patients
P. Abreu, E. Azevedo, N. Fontes, J. Correia, N. Marçal, Hospital S. João,
Portugal
41

Scientific Programme Friday, May 23, 2003
14.00–16.00 Auditorium III
42
Oral Session: Cardiovascular Topics: PFO and IMT
Chairs: J.L. Mas, France and N. Futrell, USA
14.00–14.10 Percutaneous left atrial appendage occlusion to prevent stroke in
patients with atrial fibrillation: early and mid-term results
S.H.U. Ostermayer, M. Reschke, T. Trepels, K. Billinger, M. Lesh, T. Nakai,
H. Sievert, Cardiovascular Center Bethanien, Germany
14.10–14.20 Association between right-to-left shunts and brain lesions in sport
divers
T. Gerriets, K. Tetzlaff, A. Hutzelmann, T. Liceni, G. Kopiske, N. Struck,
M. Reuter, M. Kaps, Justus-Liebig University, Germany
14.20–14.30 Differential stroke pattern on diffusion MRI among PFO patients with
and without atrioseptal aneurysm
E. Santamarina, C.A.Molina, J.F. Arenillas, J. Montaner, M. Ribo, R. Huertas,
J. Alvarez-Sabin, A. Rovira, E. Grive, Hospital Vall d'Hebron, Spain
14.30–14.40 Transcatheter closure of patent foramen ovale for secondary prevention
of TIAs and strokes: acute results and follow up in 597 patients
K. Billinger, M. Reschke, T. Trepels, S. Ostermayer, E. Zadan, K. Horvath,
H. Sievert, Cardiovascular Center Bethanien, Germany
14.40–14.50 Atrial fibrillation following catheter closure of interatrial
communications: single centre experience in 1,184 patients
T. Trepels, S. Ostermayer, K. Billinger, H. Sievert, Cardiovascular Center
Bethanien, Germany
14.50–15.00 Patent foramen ovale with presumed paradoxical embolism:
percutaneous closure or antithrombotic therapy?
V. Thijs, M. Schrooten, W. Budts, UZ Leuven, Belgium
15.00–15.10 Magnitude of intracranial artery disease in severe coronary heart
disease patients
J.I. Tembl, M.A. Arnau, A. Lago, E. Fages, I. Boscá, A. Osa, M. Palencia,
Hospital Universitari La Fe Valencia, Spain

15.10–15.20 Oral anticoagulation in patients with atrial fibrillation: influence of
pre-existing dementia on prescription before stroke in practice
C. Lefebvre, D. Deplanque, H. Henon, F. Pasquier, D. Leys, University of Lille,
France
15.20–15.30 Comparison of in vivo carotid IMT and carotid wall thickness
measured with a novel method (comparison of in vivo and
post-mortem data)
S. Molnar, L. Kerenyi, M. Ritter, T. Magyar, E.B. Ringelstein, L. Csiba,
University of Debrecen, Medical and Health Science Center, Hungary
15.30–15.40 Is the common carotid artery intima media thickness predictor of
stroke outcome?
P. Talelli, J. Ellul, G. Gioldasis, G. Terzis, A. Chrisanthopoulou,
T. Papapetropoulos, University of Patras, Greece
15.40–15.50 Gene polymorphisms causing mild hyperhomocysteinemia and
thrombophilia – possible risk factors for spontaneous cervical artery
dissections?
U. Mueller, T. Wiest, A. Grau, T. Brandt, C. Grond-Ginsbach, University of
Heidelberg, Germany
15.50–16.00 Fibrinogen and fibrinolysis in carotid arterial wall in patients with
advanced atherosclerosis
J. Krupinski, E. Catena, R. Vila, M. Cairols, L. Badimon, F. Rubio,
Hospital Universitario de Bellvitge, Spain
16.00–17.30 Poster Session II
Chairs: L. Csiba, Hungary, T. Els, Germany, A. Hetzel, Germany and
K. Lees, United Kingdom
(see pages 79–105)
43

Scientific Programme Friday, May 23, 2003
17.30–19.00 Auditorium II
44
Satellite Symposium organised by EUSI:
Controversies in Stroke Management
Chair: W. Hacke, Germany
Carotid stenting
Standard of care
M. Forsting, Germany
Unproved experimental procedure
D. Leys, France
Hypothermia
The most promising neuroprotection
T.S. Olson, Denmark
A risky, difficult and experimental procedure
S. Schwab, Germany
Antithrombotic combination therapy
Ready for prime time
H.C. Diener, Germany
Careful with extrapolation
P. Bath, United Kingdom

17.30–19.00 Auditorium III
Stroke Units in Europe: Linking Practice with Evidence
Joint Symposium Organised in Collaboration with the
Cochrane Stroke Group, Stroke Unit Trialists Collaboration
and European Stroke Unit Group
Review of admission/discharge policy and intensity of care for acute
stroke around Europe
Chairs: P. Sandercock, United Kingdom and A. Czlonkowska, Poland
17.30–17.35 Introduction
L. Candelise, Italy
17.35–17.50 Lessons from the stroke unit trials on admission/discharge policy and
intensity of care for acute stroke
P. Langhorne for the SUTC, United Kingdom
17.50–18.00 The Swedish experience
K. Asplund, Sweden
18.00–18.10 The Italian experience
R. Sterzi for PROSIT collaborators, Italy
18.10–18.50 Examples from around Europe
Up to 7 brief presentations, selected from poster submissions
18.50–19.00 Panel discussion (implementing the evidence) and concluding
remarks to identify key research questions
Co-Chairs: S. Ricci, Italy and C. Wolfe, United Kingdom
Panelists: M. Brainin, Austria, J. Bogousslavsky, Switzerland, G. Boysen,
Denmark, D. Bereczki, Hungary, O. Busse, Germany, M. Dennis,
United Kingdom, J. Ferro, Portugal, M. Hommel, France, B. Indredavik,
Norway, G. Micieli, Italy
45

Scientific Programme Saturday, May 24, 2003
08.30–10.30 Auditorium I
46
Oral Session: ICH and SAH
Chairs: S. Blecic, Belgium and J. van Gijn, The Netherlands
08.30–08.40 Headache and risk of subarachnoid haemorrhage (SAH):
a population-based case-control study
K.N. Carter, N. Anderson, K. Jamrozik, G. Hankey, C.S. Anderson, Australasian
Co-operative Research on Subarachnoid Haemorrhage Study (ACROSS) Group,
Clinical Trials Research Unit, University of Auckland, New Zealand
08.40–08.50 Magnetic resonance imaging in experimental subarachnoid
haemorrhage
W. van den Bergh, A. Algra, G. Rinkel, Department of Neurosurgery,
UMC Utrecht, The Netherlands
08.50–09.00 Repeated screening for intracranial aneurysms in familial
subarachnoid haemorrhage
M.J. Wermer, G.J.Rinkel, Rudolf Magnus Institute for Neurosciences,
University Medical Centre Utrecht, The Netherlands
09.00–09.10 Electrocardiographic abnormalities and serum magnesium in patients
with subarachnoid hemorrhage
W. van den Bergh, A. Algra, G. Rinkel, UMC Utrecht, The Netherlands
09.10–09.20 Psychiatric disturbances after subarachnoid haemorrhage
C. Menger, L. Caeiro, J.M. Ferro, R. Albuquerque, M.L. Figueira, Hospital
Santa Maria, Portugal
09.20–09.30 DD genotype of ACE gene is a risk factor for spontaneous
intracerebral haemorrhage
A. Slowik, T. Dziedzic, J. Pera, W. Turaj, P. Szermer, L. Sobanska,
A. Borratynska, D.A. Figlewicz, A. Szczudlik, Jagiellonian University, Poland
09.30–09.40 No evidence of “ischemic penumbra” in intracerebral hemorrhage:
a PWI/DWI study
K. Butcher, M.M. Parsons, T. Baird, P. Desmond, B. Tress, S. Davis,
Royal Melbourne Hospital, Australia

09.40–09.50 Risk of ICH and arterial versus cardiac origin of cerebral ischaemia:
analysis of individual patient data from 9 trials: an update
M.J. Ariesen, A. Algra, P.J. Koudstaal, P.M. Rothwell, C. VanWalraven,
Dutch TIA, SPIRIT, UK TIA, EAFT, AFASAKI-II, SPAF I-II and PATAF Study Groups,
University Medical Centre Utrecht, The Netherlands
09.50–10.00 Linear hyperintensity objects in the cerebral white matter may predict
the hypertensive intracerebral hemorrhage
M. Hiroki, K. Miyashita, S. Hirai, H. Fukuyama, Human Brain Research Center,
Kyoto University Graduate School of Medicine, Japan
10.00–10.10 Temporal profile of matrix metalloproteinases (MMPS) and their
inhibitors (TIMPS) after spontaneous intracerebral hemorrhage.
Relationship to clinical and radiological outcome
J. Alvarez-Sabín, S. Abilleira, P. Delgado, C.A. Molina, J.F. Arenillas,
E. Santamarina, J. Monasterio, J. Montaner, Neurovascular Research
Laboratory, Stroke Unit, Vall d'Hebron Hospital, Spain
10.10–10.20 Safety of cessation or reinstitution of anticoagulants in patients with
intracranial hemorrhage and a high cardio embolic risk
N. Akhtar, N. Dean, H. Lari, K. Khan, M. Saqqur, F. Orourke, M. Moratuglu,
A. Shuaib, Stroke Unit, University of Alberta Hospital, Canada
10.20–10.30 Safety and preliminary efficacy of activated recombinant factor VII
(Novoseven ® ) in acute intracerebral haemorrhage
T. Steiner, S. Mayer, N. Brun, University of Heidelberg, Germany
47

Scientific Programme Saturday, May 24, 2003
08.30–10.30 Auditorium II
48
Oral Session: Neuroimaging: MRI and fMRI
Chairs: R. von Kummer, Germany and J.C. Baron, United Kingdom
08.30–08.40 PET and DW/PW-MRI in acute stroke: identification of impaired
neuronal integrity and cerebral hypoperfusion
J. Sobesky, U. Smekal, L. Kracht, F. Lehnhardt, C. Dohmen, M. Neveling,
W.D. Heiss, University of Cologne and Max Planck Institute for Neurologic
Research, Germany
08.40–08.50 Assessment of infratentorial acute ischemic stroke with
diffusion-weighted-imaging (DWI)
C. Lie, J. Hirsch, S. Schwenk, K. Szabo, M.G. Hennerici, A. Gass,
Universitätsklinikum Mannheim, Germany
08.50–09.00 Inter-ictal cellular energy reserves in migraineurs with prolonged
aura or coma and migrainous stroke: a brain 31P-MR spectroscopy
study
U. Schulz, A.M. Blamire, R.G. Corkill, P. Styles, P. Davies, P.M. Rothwell,
Stroke Prevention Research Unit, University Department of Clinical Neurology,
United Kingdom
09.00–09.10 PWI maps as signatures of early clinical outcome and infarct
volume in acute ischemic stroke
S. Pedraza, C. Guergue, J. Mendez, J. Vera, Y. Silva, A. Davalos,
Hospital Josep Trueta, Spain
09.10–09.20 MR diffusion and perfusion abnormalities in ischaemic stroke –
patterns of sub-regional change and tissue recovery
A.C.S. Rivers, P.A. Armitage, T. Carpenter, P.J. Hand, M.S. Dennis,
J.M. Wardlaw, University of Edinburgh, United Kingdom
09.20–09.30 Diffusion-weighted MR-imaging during the early phase of global
cerebral hypoxia: a predictor for clinical outcome?
T. Els, J. Klisch, R. Kubalek, J. Kassubek, M. Herpers, C.H. Lucking,
University of Freiburg, Germany

09.30–09.40 Window narrowing – a new method for standardised assessment of
the ischemic centre in CT based brain perfusion maps
D.G. Nabavi, S.P. Kloska, E.M. Nam, A. Allroggen, E. Klotz, W. Heindel,
E.B. Ringelstein, University Hospital of Münster, Germany
09.40–09.50 The ischaemic penumbra in white and grey matter of brain after
ischaemic stroke; an 18FMISO PET study
A.L.E. Falcao, D.C. Reutens, R. Markus, T. Phan, P. Wright, S.J. Read,
H. Tochon-Danguy, J. Sachinidis, D.W. Howells, G.A. Donnan,
National Stroke Research Institute, Australia
09.50–10.00 Hemodynamic assessment by diffusion-weighted MRI, proton MR
spectroscopic imaging and SPECT in symptomatic patients due to the
occlusive major-vessel
K. Kamada, K. Mitsumori, T. Shogo, I. Yoshinobu, Chitose City Hospital, Japan
10.00–10.10 Plasmatic level of matrix metalloproteinase-9 predicts the extent of
diffusion-weighted image lesion in human hyperacute stroke
M. Ribó, J. Montaner, A. Rovira, C.A. Molina, J. Monasterio, J. Arenillas,
P. Chacón, J. Alvarez-Sabín, Neurovascular Research Laboratory, Stroke Unit,
Vall d'Hebron Hospital, Spain
10.10–10.20 Visualisation of cerebral ischemia without contrast agent using
power pulse-inversion harmonic imaging
F. Perren, R. Kern, A. Gass, M.G. Hennerici, S. Meairs, University of
Heidelberg, Universitätsklinikum Mannheim, Germany
10.20–10.30 Noninvasive measurement of regional cerebral blood flow by near
infrared spectroscopy and indocyaningreen dye dilution
E. Keller, A. Nadler, H. Alkadhi, S. Kollias, Y. Yonekawa, P. Niederer,
University Hospital Zürich, Switzerland
49

Scientific Programme Saturday, May 24, 2003
08.30–10.30 Auditorium III
50
Oral Session: Management and Economics
Chairs: H.C. Diener, Germany and P. Rothwell, United Kingdom
08.30–08.40 Complaints and malpractice in stroke care
A. Johansson, A. Staaf, K. Asplund, Department of Public Health and Clinical
Medicine, Sweden
08.40–08.50 The use of MORUCOS (Model of Resource Utilisation, Costs and
Outcomes for Stroke) for the cost-effectiveness analysis and
prioritisation of selected stroke interventions
M. Moodie, R. Carter, C. Mihalopoulos, H. Dewey, B. Chambers,
National Stroke Research Institute, Australia
08.50–09.00 Pre- and in-hospital delays from stroke onset to intra-arterial
thrombolysis
K. Nedeltchev, M. Arnold, C. Brekenfeld, J. Isenegger, L. Remonda, G. Schroth,
H.P. Mattle, University of Bern, Switzerland
09.00–09.10 Is there equal access to longer-term stroke care?
Findings from the South London Stroke Register
C. Coshall, K. Tilling, C. McKevitt, C. Wolfe, King's College London,
United Kingdom
09.10–09.20 Heparin in acute ischemic stroke: study results and clinical reality
M. Daffertshofer, E. Grips, M.G. Hennerici, German Stroke Units, University
Heidelberg, Universitätsklinikum Mannheim, Germany
09.20–09.30 Adequacy of documentation in medical records of stroke patients
B. Norrving, B. Nilsson, K. Wittlöv, M. Sederholm, University Hospital Lund,
Sweden
09.30–09.40 Stroke risk factor management: are there inequalities in treatment?
C. Coshall, K. Tilling, C. McKevitt, C. Wolfe, King's College London,
United Kingdom

09.40–09.50 Risk factor change after cryptogenic stroke in young patients.
The PFO ASA study
C. Arquizan, E. Touzé, M. Zuber, C. Lamy, J.L. Mas, Patent Foramen Ovale and
Atrial Septal Aneurysm Study Group, Hospital Sainte Anne, France
09.50–10.00 Comprehensive shared care following stroke; effective secondary
intervention for vascular risk factors and deression in a high-risk
group
J. Joubert, S. Davis, C. Reid, L. Johnsen, D. Ruth, D. Barton,
Royal Melbourne Hospital, Australia
10.00–10.10 Does caregiver training and support in stroke reduce costs of care?
L. Kalra, A. Evans, I. Perez, A. Melbourn, A. Patel, M. Knapp, Guy's,
King's and St Thomas's School of Medicine, King's College London,
United Kingdom
10.10–10.20 The time course of resource use and costs following ischemic stroke
J.J. Caro, K. Migliaccio-Walle, K.J. Ishak, J.A. O'Brien, Caro Research
Institute, USA
10.20–10.30 SAFE II Study: why anticoagulants still remain underused in Europe?
Part 1-A survey from general practitioners and cardiologists
D. Deplanque, D. Leys, L. Parnetti, R. Schmidt, J. de Reuck , J. Ferro, J.L. Mas,
V. Gallai, Neurology and Pharmacology Departments, CHRU Lille, France
51

Scientific Programme Saturday, May 24, 2003
10.30–11.00 Auditorium I
52
Invited Lecture: Current Concepts in Reconstructive
Neurobiology
O. Wiestler, Germany
11.00–11.30 Coffee Break
11.30–12.00 Auditorium I
Award Presentations
J. Bogousslavsky, Switzerland

12.00–13.05 Auditorium I
Oral Session: News from Large Clinical Trials
Chairs: J.P. Mohr, USA and N.G. Wahlgren, Sweden
12.00–12.15 Ximelagatran compared with Warfarin for prevention of stroke and
systemic embolism in patients with non-valvular atrial fibrillation:
SPORTIF III
H.C. Diener, SPORTIF III Investigators, University Essen, Germany
12.15–12.30 Effect of estrogen plus progestin on stroke in the Women’s Health
Initiative
A.E. Baird, S. Wassertheil-Smoller, National Institute of
Neurological Disorders and Stroke, USA
12.30–12.40 Abciximab in emergent stroke treatment:
influence of time and other variables on outcome
A. Davalos, Hospital Josep Trueta, Spain
12.40–12.50 Dipyridamole in stroke prevention:
the effect of dipyridamole on blood pressure
E. De Schryver, ESPRIT Study Group, University Medical Center Utrecht,
The Netherlands
12.50–13.05 Initial findings of the rt-PA acute stroke treatment review panel
T.J. Ingall, W.M. O'Fallon, T.A. Louis, V. Hertzberg, L.R. Goldfrank, K. Asplund,
Mayo Clinic Scottsdale, USA
13.05–13.15 Auditorium I
Closure and Announcement of ESC 2004
M.G. Hennerici, Germany
53

Poster Sessions Thursday, May 22, 2003
54
Poster Session I
Chairs: S. Davis, Australia, W. Hacke, Germany and J. Ferro, Portugal
Epidemiology
1 Estimating stroke unit bed numbers for Scotland: the Scottish Borders
Stroke Study Poisson bed-occupancy model
P. Syme, S. Litster, K. McKinnon, Borders General Hospital, University of
Edinburgh, United Kingdom
2 Risk of stroke in patients with atrial fibrillation when anticoagulation
is adjusted for endoscopic procedures during endoscopic procedures
D. Blacker, E. Wijdicks, R. McClelland, Mayo Clinic, USA
3 The prevalence of stroke survivors in rural South Africa: results from
the Southern Africa Stroke Prevention Initiative rural Agincourt field
site
M. Connor, B. Casserly, C. Dobson, M. Thorogood, C. Warlow,
SASPI Project Team, University of the Witwatersrand, South Africa
4 Secondary stroke prophylaxis and health seeking behaviour in stroke
survivors in rural South Africa: report from the SASPI study
M. Connor, M. Thorogood, B. Casserly, C. Dobson, C. Warlow,
SASPI Project Team, University of the Witwatersrand, South Africa
5 Death certification errors in the Scottish Borders Stroke Study (SBSS)
H. Clinkscale, P. Syme, Borders General Hospital, United Kingdom
6 Medium and long-term variability in blood pressure in patients with
cerebrovascular disease: implications for clinical practice and
research
R.L. Cuffe, S.C. Howard, A. Algra, C.P. Warlow, P.M. Rothwell,
Stroke Prevention Research Unit, Department of Clinical Neurology,
University of Oxford, United Kingdom
7 Differences in frequency of risk factors by aetiogical subtype of
ischaemic stroke in population-based studies
U. Schulz, P.M. Rothwell, Stroke Prevention Research Unit,
University Department of Clinical Neurology, United Kingdom

8 Studies of risk factors for different aetiological subtypes of ischaemic
stroke should be population-based
U. Schulz, P.M. Rothwell, Stroke Prevention Research Unit, University
Department of Clinical Neurology, United Kingdom
9 Prevalence of the multiple modifiable risk factors for first ischemic
stroke
D.I. Hadjiev, P.P. Mineva, M.I. Vukov, Medical University, Sofia and Thracian
University, Bulgaria
10 What determines handicap after stroke? The North East Melbourne
Stroke Incidence Study (NEMESIS)
J.W. Sturm, G.A. Donnan, H.M. Dewey, R.A.L. Macdonell, A.K. Gilligan,
A.G. Thrift, National Stroke Research Institute, Australia
11 Should intensive preventive treatment be continued indefinitely after
a transient ischaemic attack?
E. Flossmann, T.G. Clark, M.F. Murphy, P.M. Rothwell, Stroke Prevention
Research Unit, Radcliffe Infirmary, University of Oxford, United Kingdom
12 Older stroke patients in Europe: the forgotten group?
A. Bhalla, R. Grieve, K. Tilling, A. Rudd, C. Wolfe, Public Health Department,
Guy’s, King’s and St Thomas’ School of Medicine, United Kingdom
13 Area-based deprivation is associated with ischaemic stroke risk
factors and readmission due to any vascular event in the Greater
Glasgow Health Board (GGHB) area
S. Aslanyan, C.J. Weir, K.R. Lees, Division of Cardiovascular and Medical
Sciences, University of Glasgow, United Kingdom
14 Worldwide comparison of age-standardised stroke incidence with
true age-adjusted stroke risk
P. Syme, A. Byrne, R. Chen, Borders General Hospital, University of Edinburgh,
United Kingdom
15 Not all stroke patients who present to hospital are admitted.
How do these cases differ from admitted cases? Results from
North East Melbourne Stroke Incidence Study (NEMESIS)
A.K. Gilligan, J.W. Sturm, H.M. Dewey, G.A. Donnan, R.A. Macdonell,
A.G. Thrift, National Stroke Research Institute, Australia
55

Poster Sessions Thursday, May 22, 2003
56
16 Prevalence of self-reported stroke among older Singapore Asians –
an inter-racial comparison
N. Venketasubramanian, S.M. Saw, C.Y. Hong, L. Tan, S. Sahadevan, J.J. Chin,
E.S. Krishnamoorthy, V. Ramachandran, National Neuroscience Institute,
Singapore
17 Inhospital delays in patients with acute stroke
G.J. Jungehülsing, C.H. Nolte, K. Rossnagel, S. Roll, J. Müller-Nordhorn,
A. Reich, S.N. Willich, K.M. Einhäupl, A. Villringer, Charité Berlin, Germany
18 Declining incidence and mortality of stroke in persons
25 to 74 years in Finland
J. Sivenius, P. Immonen-Räihä, A. Lehtonen, C. Sarti, J. Torppa, J. Tuomilehto,
V. Salomaa, University of Kuopio, Finland
19 Ischaemic stroke outcomes by aetiological (TOAST) subtypes
R. McGovern, C. Hajat, M. Patel, A. Rudd, C. Wolfe, Department of Public
Health Sciences, King's College London, United Kingdom
20 Aetiological subtypes of strokes: the relationship between the index
stroke subtype and recurrence stroke subtype
R. McGovern, C. Hajat, A. Rudd, C. Wolfe, Department of Public Health
Sciences, King's College London, United Kingdom
21 Survival after urinary catheterisation in the wirral stroke B&B cohort
study
J.A. Barrett, H. Pandya, V. Little, P. Weir, M.E. Barrett, R. Plant, M. Pritchard
Howarth, G. Sangster, C. Jack, C.L. Watkins, Wirral Stroke Service,
United Kingdom
22 Predictors of in-hospital mortality in acute stroke in very old people
C. Tejero, E. Mostacero, J.A. Mauri, L.F. Pascual, L.J. Lopez del Val, S. Santos,
Unidad de ictus, Servicio de Neurología, Hospital Clínico Zaragoza, Spain

23 Air pollution and cerebrovascular disease
M.L. Cuadrado, J.M. San Román, C. Guijarro, M.I. González-Anglada,
J.L. Dobato, Ciencias de la Salud, Universidad Rey Juan Carlos,
Fundación Hospital Alcorcón, Spain
Diagnosis and Treatment with Ultrasound
1 Parameters of cerebral perfusion in bilateral contrast harmonic
imaging with second generation contrast specific agents
J. Eyding, W. Wilkening, C. Krogias, S. Meves, T. Postert, St. Josef Hospital,
Ruhr University Bochum, Germany
2 Assessment of brain perfusion by ultrasound in a one-vessel
occlusion model in rats
M. Fatar, K. Tiemann, M. Stroick, B. Luederitz, M.G. Hennerici, S. Meairs,
Dept. of Neurology, Klinikum Mannheim, University of Heidelberg, Germany
3 Contrast diminution imaging of the human brain – first experience on
healthy volunteers and acute stroke patients
K. Meyer, J. Lahmann, G. Seidel, Universitätsklinikum Schleswig-Holstein,
Campus Lübeck, Klinik für Neurologie, Germany
4 Is there a relationship among carotid stenosis, symptoms and
cerebrovascular reactivity (CVR) evaluated by transcranial Doppler
with Diamox test?
V.F. Zetola, A.R. Massaro, L.C. Werneck, E.M. Novak, M. Scaff,
Universidade Federal do Parana, Brazil
5 Ischemic stroke in young adults. Is neurosonology associated to the
prevalence of classical atherosclerosis factors?
M.J. Moltó-Jordà, M. Alvarez-Sauco, A. Pampliega-Pérez, J. Carneado-Ruiz,
R. Hernández-Lorido, F. Gracia-Fleta, S. Bustos-Terol, Hospital General
Universitari d'Alacant, Spain
6 Enhancement of enzymatic fibrinolysis with ultrasound and
microbubbles
P. Cintas, F. Nguyen, B. Boneu, V. Larrue, University of Toulouse, France
57

Poster Sessions Thursday, May 22, 2003
58
7 Ultrasound perfusion imaging in acute middle cerebral artery
infarction
G. Seidel, K. Meyer, G. Berdien, J. Lahmann, University Hospital
Schleswig-Holstein, Campus Lübeck, Germany
8 Reduced frequency of embolic signals in severe symptomatic carotid
stenosis with poststenotic arterial narrowing and/or flow velocity
reduction
T. Blaser, S. Guhr, H. Lotze, C.W. Wallesch, M. Goertler, Otto-von-Guericke
University Magdeburg, Germany
9 “To see or not to see”: a prospective study comparing transcranial
color coded duplex sonography to transcranial Doppler in stroke
patients
F. Perren, R. Kern, R. Prager, M.G. Hennerici, S. Meairs,
Universitätsklinikum Mannheim, University of Heidelberg, Germany
10 A rapid non-invasive method to visualise ruptured aneurysms in the
emergency room: three-dimensional unenhanced power Doppler
imaging
F. Perren, J. Gaa, P. Horn, P. Schmiedek, M.G. Hennerici, S. Meairs,
Universitätsklinikum Mannheim, Germany
11 Interobserver agreement of frequency and velocity parameters
assessed by Doppler/duplex sonography in patients with
> 50 % internal carotid stenosis
S.G. Guhr, T.B. Blaser, S.K. Krueger, C.W.W. Wallesch, M.G. Goertler,
Universitiy of Magdeburg, Germany
12 Interobserver agreement for diameter measurements on colour-coded
duplex images in patients with > 50 % internal carotid stenosis
S. Guhr, T. Blaser, C.W. Wallesch, M. Goertler, Universitiy of Magdeburg,
Germany
13 Hematologic factors and transcranial Doppler velocities
C. Togay-Isikay, N. Uzuner, D. Gücüyener, G. Özdemir,
Osmangazi University, School of Medicine, Turkey

14 Relevance of hemodynamc impairment to brain lesion in
asymptomatic carotid stenosis (ACAS): transcranial Doppler (TCD)
magnetic resonance angiography (MRA) correlation
Y. Lee, D. Kim, J. Min, S. Park, Seoul Municipal Boramae Hospital and
Seoul National University, South Korea
15 Measurement of carotid stenosis: comparisons between duplex and
angiogram, and endarterectomy specimen
L.J.H. Lee, Department of Neurology, National Health Insurance Corporation
Ilsan Hospital, South Korea
16 Transcranial Doppler measurements in parenchymal hemorrhage
L. Csiba, G. Settakis, D. Bereczki, P. Bagyi, J. Kollar, B. Fulesdi,
University of Debrecen, Medical and Health Science Center, Hungary
Acute Stroke – Symptoms and Clinical Diagnosis
1 Cognitive and behavioural aspects affecting early referral of acute
stroke patients; stroke related self-care responses
K. Makinde, M. Shah, D. Schelewa, P. Thomas, Prince Philip Hospital,
United Kingdom
2 Different patterns of silent infarcts and early ischemic changes in
acute stroke patients
F. Corea, N. Tambasco, R. Luccioli, E. Ciorba, L. Parnetti, V. Gallai,
University of Perugia, Italy
3 Anterior cerebral artery involvement:
early CT-scan changes in stroke patients
N. Tambasco, F. Corea, R. Luccioli, V. Bocola, G.P. Pelliccioli, L. Parnetti,
V. Gallai, University of Perugia, Italy
4 Reliability of estimating Scandinavian stroke scale scores from
hospital admission records
M. Barber, M. Fail, M. Shields, D.J. Stott, P. Langhorne, Academic Section of
Geriatric Medicine, Glasgow Royal Infirmary, United Kingdom
59

Poster Sessions Thursday, May 22, 2003
60
5 Should non-neurologists see TIA patients?
S.S.M. Razvi, P. Crawford, I. Bone, K.W. Muir, Southern General Hospital,
Glasgow, United Kingdom
6 Intravenous MAGnesium Efficacy for Stroke (IMAGES) Trial –
baseline data and trial power
K.R. Lees, IMAGES Study Group, University of Glasgow, United Kingdom
7 Usefulness of the OCSP classification in the assessment of cerebral
ischemia in a population-based study
F. De Santis, C. Marini, S. Sacco, T. Russo, R. Della Cagna, A. Carolei,
University of L'Aquila, Italy
8 Clinical features of suspected acute stroke patients referred to an
emergency room
A. Mohd Nor, S.J. Louw, A.G. Dyker, M. Davis, B. Sen, G.A. Ford, The Freeman
Hospital and University of Newcastle upon Tyne, United Kingdom
9 Inter-observer agreement between paramedic recorded neurological
signs with face arm speech test and physician assessment in acute
stroke/TIA referrals
A. Mohd Nor, J. Davis, S.J. Louw, C. McAllister, A.G. Dyker, M. Davis, B. Sen,
D. Jenkinson, G.A. Ford, The Freeman Hospital and University of Newcastle
upon Tyne, United Kingdom
10 Central, anteromedial and posterolateral infarcts of thalamus:
three new types
E. Carrera, P. Michel, J. Bogousslavsky, University Hospital Lausanne,
Switzerland
11 Is OSCP a valid indicator for ischemic stroke localisation and
outcome compared to CT scan?
V. Caso, P. Paciaroni, G. Silvestrelli, F. Corea, M. Venti, P. Milia, R. Scaroni,
L. Parnetti, V. Gallai, Perugia General Hospital, Italy
12 Bilateral paramedian thalamic infarction due to infarction of the
artery of percheron: a case report
D. Sajeel, D. Heaney, P. Gompertz, Barts and the London Hospital,
United Kingdom

13 Intractable hiccup in acute ischemic stroke
K.M. Yoo, B.G. Yoo, K. Kim, J.K. Cha, Kosin University College of Medicine,
South Korea
AS Monitoring and Complications – Stroke Units
1 Effect of age on access to stroke care in England, Wales and Northern
Ireland: results from the National Sentinel Audits of Stroke 1998–2002
A.G. Rudd, D. Lowe, A. Hoffman, P. Irwin, M. Pearson, Royal College of
Physicians London, United Kingdom
2 Is the gag reflex useful in management of acute stroke?
D.J. Ramsey, D.G. Smithard, N. Donaldson, L. Kalra, Guy's,
King's & St Thomas' School of Medicine, United Kingdom
3 Morphological changes in the brain of rats in acute period of
experimental hemorragic stroke
A.N. Makarenko, R. Poznyakov, M. Evzelman, A. Kultcikov,
I. Vasilyeva, General Pathology Department, Oryol State University,
Russian Federation
4 Blood gases early after stroke
C. Roffe, S. Sills, School of Medicine, Keele University, United Kingdom
5 How to save 24 minutes in thrombolysis for acute ischemic stroke
J. Martí-Fàbregas, D. Cocho, R. Belvís, A. Aleu, X. Pagonabarraga,
M.D. García, B. Marín, L. Molina, J. Díaz, J.L. Martí-Vilalta, Hospital de la
Santa Creu i Sant Pau, Spain
6 The incidence of deep venous thrombosis detected by Doppler
ultrasound in hemiplegic Asian stroke patients is comparable to
western stroke populations
A. Sim, H.H. The, C.F. Chan, H.B. Pey, H.M.M. Chang, M.K. Teoh, I. Husein,
P. Lim, C. Chen, National Neuroscience Institute, Singapore General Hospital
Campus, Singapore
61

Poster Sessions Thursday, May 22, 2003
62
7 Comparison of MMP-2 and MMP-9 kinetics in stroke and lacunar
stroke
M. Stroick, M. Fatar, E. Senn, S. Kuehl, M.G. Hennerici, Dept. of Neurology,
Klinikum Mannheim, University Heidelberg, Germany
8 Cerebrovascular risk factors and lacunar stroke outcome.
Have they some influence?
V. Mejías, E. Díez-Tejedor, B. Fuentes, S. Monteagudo, J. Gracia, S. Escalante,
J. Gracia San Román, University Hospital La Paz, Spain
9 Perfusion CT for the prediction of large hemispheric infarctions in
patients with hyperacute stroke
E.M. Nam, S.P. Kloska, F. Stögbauer, E. Klotz, W. Heindel, E.B. Ringelstein,
D.G. Nabavi, University of Münster, Germany
10 Nocturnal oxygen saturation in patients with acute stroke:
does it change over the first three nights of admission to hospital
C. Roffe, S. Sills, The Medical School, Keele University, United Kingdom
11 Depression following a stroke: how good are clinicians at detecting
and treating it?
E. Lightbody, L. Daniels, H. Dickinson, M. Jack, M. Leathley, M. van den Broek,
C. Watkins, University of Central Lancashire, United Kingdom
12 Stroke prevention and management in primary care in the UK
E. Lightbody, I. Benett, H. Hosker, M. Leathley, C. Watkins,
University of Central Lancashire, United Kingdom
13 Thrombolysis for acute ischaemic stroke: are we ready in the UK?
I.M. Shah, C.H. McAlpine, D.J. Stott, University of Glasgow, United Kingdom
14 Infectious serious adverse events (iSAE) are independently
associated with poor outcome after acute ischaemic stroke
S. Aslanyan, C.J. Weir, H.C. Diener, M. Kaste, K.R. Lees, Division of
Cardiovascular and Medical Sciences, University of Glasgow, United Kingdom
15 Feeding stroke patients: a survey of current practice in UK hospitals
M.S. Dennis, G. Cranswick, R. Flaig, S. Lewis, C. McLaverty, C. Williams,
International Stroke Trials (IST) Collaboration – FOOD, University of Edinburgh,
United Kingdom

16 Stroke units and mixed stroke services in seven Italian regions:
the PROSIT study
L. Candelise, G. Micieli, R. Sterzi, PROSIT, IRCCS Ospedale Maggiore
Policlinico, Italy
17 Hypoxia and abnormal breathing patterns in hyperacute stroke
A. Rowat, J. Wardlaw, M. Dennis, R. Lindley, P. Andrews,
University of Edinburgh, United Kingdom
18 Stroke units in real life compared to research units. Results from the
National Audit England, Wales and Northern Ireland
A. Hoffman, D. Lowe, P. Irwin, M. Pearson, A. Rudd, Royal College of
Physicians, United Kingdom
19 Can a stroke care monitoring unit improve the results of a
conventional stroke unit?
F. Nombela, R. González-Santiago, M. Tamayo, J. Vivancos,
Hospital Universitario De La Princesa, Spain
20 Utility of serum GFAP in monitoring acute MCA territorial infarction
C. Foerch, O. Singer, T. Neumann-Haefelin, A. Raabe, M. Sitzer,
J.W. Goethe University, Germany
21 Admission characteristics, intensity of care and outcome at the
Debrecen Stroke Unit at the turn of the millennium
D. Bereczki, I. Fekete, B. Fülesdi, A. Valikovics, K. Fekete, L. Csiba,
University of Debrecen, Hungary
22 Cerebral (middle cerebral artery blood velocity, pulsatility index) and
systemic (blood/pulse pressure, cardiac output, augmentation index)
haemodynamics during acute stroke
P. Rashid, J. Leonardi-Bee, B. Whysall, P.M. Bath, University of Nottingham,
United Kingdom
23 What are the consequences of urinary catheterisation in patients
with acute stroke?
J. Kwan, P. Hand, M. Dennis, P. Sandercock, Western General Hospital,
University of Edinburgh, United Kingdom
63

Poster Sessions Thursday, May 22, 2003
64
24 Association between blood pressure values and edema formation in
patients with acute stroke
G. Tsivgoulis, A. Synetos, K. Spengos, V. Kotsis, E. Manios,
P. Konstantopoulou, K. Vemmos, University of Athens, Medical School, Greece
25 Acute prolonged corrected QT interval is related to severe stroke
A.H. Christensen, A.F. Christensen, G. Boysen, Bispebjerg Hospital, Denmark
Acute Stroke – Treatment Concepts
1 Thrombolysis for stroke in elderly patients
C. Vatankhah, M. Seidl, P. Erban, S. Sauerbruch, M. Dittmar, W. Jakob,
G. Ickenstein, M. Horn, University of Regensburg, Germany
2 Stroke network with regional stroke care units and high speed
telemedicine in Germany. The Telemedic Pilot Project of an
Integrative Stroke Care (TEMPIS) in Eastern Bavaria
J. Schenkel, M.L.J. Wimmer, M. Horn, H.J. Audebert, Städtisches
Krankenhaus München-Harlaching, Germany
3 Variation in use of antiplatelet therapy after stroke
S.C. Smith, Geratology Department, Radcliffe Infirmary, United Kingdom
4 Reduced the P-selectin expression on platelets and C-reactive
protein after statin therapy in chronic atherosclerotic ischemic stroke
J.K. Cha, K.M. Yoo, College of Medicine, Dong-A University, South Korea
5 Changes of the P-selectin expression on platelets and plasma
concentration of C-reactive protein in acute atherosclerotic infarction
treated with the loading dose of clopidogrel
W.J. Kim, J.K. Cha, College of Medicine, Dong-A University, South Korea
6 Getting started: using guidelines to develop a better stroke service
S. Smith, S. Manchanda, L. Gladman, O. Drew, Wycombe Hospital,
United Kingdom
7 Factors influencing the pre- and in-hospital management of acute
stroke – data from a Greek tertiary care hospital
J. Rudolf, E. Koutlas, G. Grivas, X. Fitsioris, G. Georgiadis,
Papageorgiou Regional General Hospital, Greece

8 Early hyperglycaemia is important in ischaemic stroke evolution
T.A. Baird, M.W. Parsons, K.S. Butcher, P.G. Colman, P.M. Desmond,
B.M. Tress, B. Chambers, T. Phanh, S.M. Davis, Royal Melbourne Hospital,
Australia
9 Efficacy of dual anti-platelet therapy in cerebrovascular disease as
demonstrated by decline in microembolic signals
R. Esagunde, M.P. Lee, H.Y. Gan, K.S. Wong, H.M.M. Chang, C. Chen,
M.C. Wong, National Neuroscience Institute, Singapore General Hospital
Campus, Singapore
10 Delayed occlusion after internal carotid artery dissection under
unfractionated heparin
J.P. Dreier, F. Lürtzing, M. Kappmeier, G. Bohner, R. Klingebiel, S. Leistner,
K.M. Einhäupl, E. Schielke, J.M. Valdueza, Neurology, Charité,
Humboldt University, Germany
11 Sources of delay to thrombolysis among acute stroke patients who
arrive at the emergency room soon after symptom onset
J.G. Merino, N. Simpson, S. Silliman, B. Quinn, S. Erenguc,
University of Florida, College of Medicine, USA
12 Acute stroke treatment with systemic thrombolysis in the clinical
practice of a single centre
A. Hartmann, M. Marx, H.C. Koennecke, University Hospital Benjamin
Franklin, Free University Berlin, Germany
13 Physical inactivity in acute stroke units: is a new model of care required?
A.J. Bernhardt, A. Thrift, H. Dewey, G. Donnan, National Stroke Research
Institute, Australia
14 Drug induced hypothermia reduces ischemic damage:
effects of the cannabinoid HU-210
H. Ovadia, N. Gai, R. Mechoulam, J. Weidenfeld, R.R. Leker,
Agnes Ginges Center for Human Neurogenetics, Hadassah Hospital, Israel
65

Poster Sessions Thursday, May 22, 2003
66
15 Anticoagulation therapy in stroke patients treated with intravenous
thrombolysis
A.R. Mikulik, M. Dufek, D. Goldemund, M. Reif, Cerebrovascular Center,
Masaryk University, St. Anne's Hospital, Czech Republic
16 Emergency carotid stenting for hyperacute or acute ischemic stroke
patients
T. Mori, K. Imai, M. Watanabe, H. Izumoto, T. Kamiya, Shonan Kamakura
General Hospital, Japan
17 Short-term clinical outcome after cerebral balloon angioplasty or
stenting for vertebro-basilar artery occlusive lesions in acute stroke
patients
T. Mori, K. Imai, H. Izumoto, M. Watanabe, T. Kamiya, Shonan Kamakura
General Hospital, Japan
18 Why are patients admitted within 2 hours not given thrombolysis?
D. Cocho, R. Belvís, J. Martí-Fàbregas, A. Aleu-Bonaut, X. Pagonabarraga,
D. García, B. Marín, J.L. Martí-Vilalta, Hospital de la Santa Creu i Sant Pau,
Spain
19 The effect of losartan on global and focal cerebral perfusion and
renal function in hypertensives in early ischaemic stroke
F.S. Nazir, J.R. Overell, T.E. Hilditch, K.R. Lees, University of Glasgow,
United Kingdom
20 Opportunities for secondary preventative pharmacotherapy at a
hospital-based TIA clinic
S.S.M. Razvi, P. Crawford, I. Bone, K.W. Muir, Southern General Hospital,
United Kingdom
21 Predictors of angiographic recanalisation and clinical improvement
in patients with middle cerebral artery territory infarction treated by
thrombolytics
J.H. Kwon, S.U. Kwon, C.G. Choi, J.S. Kim, Ulsan University College of
Medicine, Asan Medical Center, South Korea

22 Intravenous thrombolysis in acute ischemic stroke:
a single centre Latin American experience
A. Hoppe, P. Lavados, A. Brunser, D. Cárcamo, R. Vedugo, M. Campero,
J. Barahona, V. Diaz, I. Gonzalez, F. Vergara, Clínica Alemana de Santiago, Chile
23 The anti-inflammatory effects of aggrenox: decreased gene
expression in platelet-monocyte aggregates
A.A.S. Weyrich, B.J.R. Eyre, C.G.A. Zimmerman, D.S.M. Prescott,
University of Utah, USA
24 Neurological deterioration following early improvement in
intravenous rt-PA therapy. Possible underlying mechanisms
A. Dae-il Chang, K.C. Chung, College of Medicine, Kyung Hee University,
South Korea
25 Do we need new evidence? Planning a trial from overview data
M.G. Celani, S. Ricci, E. Righetti, L. Convito, Stroke Service USL 2 Perugia,
Italy
26 Early or late treatment of symptomatic internal carotid artery stenosis
with stent protected angioplasty?
U. Becker, T. Goldhagen, A. Mueller, D. Mucha, H. Reichmann, R. von Kummer,
University of Dresden, Germany
27 Recurrence of vascular events in patients with ischemic stroke/TIA
and atrial fibrillation with respect to different treatment strategies in
secondary prevention
S. Tentschert, S. Parigger, V. Dorda, K. Bittner, S. Greisenegger, W. Lang,
W. Lalouschek, University Hospital of Vienna, Austria
28 Endovascular treatment of acute ischemic stroke related to acute
carotid artery dissection and occlusion
S.H. Kim, A.M. Siddiqui, A.I. Qureshi, E.I. Levy, R.A. Hanel, M.R. Harrigan,
J.U. Howington, A.R. Xavier, J.F. Kirmani, L.N. Hopkins,
Department of Neurosurgery, Millard Fillmore Hospital,
State University of New York at Buffalo, USA
67

Poster Sessions Thursday, May 22, 2003
68
29 Anticoagulation vs aspirin in the treatment of acute spontaneous
cervical artery dissections
A.A. Arauz, C. Espinoza, L. Murillo, C. Cantú, F. Barinagarrementeria,
National Institute of Neurology (Mexico), Spain
Stroke Outcome
1 Are asymptomatic intracranial hemorrhages really innocuous?
D.M. Kent, L. Price, H.P. Selker, Division of Clinical Care Research,
Tufts-New England Medical Center, USA
2 Clinical outcome after thrombolysis in patients with internal carotid
artery occlusion
M. Zaletel, V. Svigelj, B. Zvan, Neurology Clinic, University Medical Center
Ljubljana, Slovenia
3 Changes in body weight at 3 months after stroke
A.C. Jonsson, I. Lindgren, B. Hallstrom, B. Norrving, A. Lindgren,
Department of Clinical Neuroscience, Universtity Hospital Lund, Sweden
4 Cerebrovascular risk factors and antithrombotic treatment on brain
infarct haemorrhagic transformation
S. Monteagudo, B. Fuentes, E. Díez Tejedor, J. Gracia, V. Mejías, S. Escalante,
University Hospital La Paz, Spain
5 Cerebrovascular risk factors and non lacunar ischemic stroke
outcome
R. Merino, E. Díez Tejedor, B. Fuentes, S. Monteagudo, J. Gracia, V. Mejías,
S. Escalante, University Hospital La Paz, Spain
6 Could previous treatment with statins have benefits in non lacunar
ischemic stroke outcome?
R. Merino, E. Díez Tejedor, B. Fuentes, J. Gracia, V. Mejías,
S. Monteagudo, S. Escalante, University Hospital La Paz, Spain
7 Correlation of size and location of hematoma with prognosis in
intracerebral hemorrhage patients
K. Khosravi, J. Lotfi, S. Nafisi, N. Sedighi, Shariati Hospital, Iran

8 Use of CT in place of MR-DWI in the three-item scale for the early
prediction of stroke recovery
V. Wright, R. Horvath, J. Chalela, J. Dambrossio, H. Yu, A. Sharma, D.W. Kang,
M. Ezzeddine, S. Warach, A.E. Baird, National Institute of Health,
National Institute of Neurological Disorders and Stroke, USA
9 The effect of stroke on carer quality of life
D. Sulch, I. Perez, M. Melbourn, L. Kalra, GKT School of Medicine,
United Kingdom
10 The effect of time on the accuracy of stroke prognosis
M. Leathley, A. Sharma, C. Sutton, C. Watkins, University of Central
Lancashire, United Kingdom
11 Intravenous rtPA in 169 acute ischemic stroke patients – safety and
efficacy in clinical routine use over a 4-year time period
O. Mielke, M. Fritzinger, M. Daffertshofer, M.G. Hennerici,
University Hospital Mannheim, Germany
12 Anxiety disorders after minor strokes
L. Bruggimann, J.M.M. Annoni, F. Staub, S. Gramigna, J. Bogousslavsky,
Lausanne University Hospital, Switzerland
13 Early asymptomatic recurrence of cervical artery dissection: 3 cases
E. Touzé, M. Zuber, C. Oppenheim, E. Méary, J.F. Meder, J.L. Mas,
Hôpital Sainte-Anne, France
14 First month prognosis in hypertensive intracerebral hemorrhage
correlated with the adapted Hemphill-Bonovich score
S. Tuta, B. Dumitriu, A. Nistorescu, C. Popa, Institute of Cerebrovascular
Diseases Bucharest, Romania
15 Spontaneous intracranial haemorrhage; which patients need
diagnostic cerebral angiography; comparative study between plain
computed tomography and cerebral angiography in HUSM
J. Abdullah, I. Abu Bakar, I.L. Shuaib, N.N. Naing, Hospital University Sains,
Malaysia
69

Poster Sessions Thursday, May 22, 2003
70
16 Three types of blood glucose level during acute ischemic stroke as
a predictor of early clinical improvement; which one is best?
J. Koo, B. Kim, O. Kwon, S. Kim, H. Bae, Eulji General Hospital,
Eulji University School of Medicine
17 One year follow-up of pharmacoeconomic and clinical
outcomes of hospitalised stroke patients in Hamilton, Canada
A.S.E. Salama, R. Goeree, R. Petrovic, G. Blackhouse,
Hamilton Health Sciences, Canada
18 Primary intracebebral haemorrhage: all Asian study
N. Poungvarin, Siriraj Hospital, Thailand
19 Cross-cultural comparisons of mild cognitive impairment. Impact and
risk factors of dementia and mild cognitive impairment in China and
USA were compaired
G. Xu, J.S. Meyer, Y. Huang, D. Liu, M. Chowdhury, M. Quach, Xijing Hospital,
China
20 Classification of outcome events in a cerebrovascular trial:
prognostic value
D.R. Jovanovic, A. Algra, J. van Gijn, University Medical Center Utrecht,
The Netherlands
21 Evaluation of a stroke scale record form for the combined assessment
of NIH, European and Scandinavian Stroke Scale
M. Goertler, G. Partscht, M. Wunderlich, U. Walter, C.W. Wallesch,
University and Municipal Hospital of Magdeburg, Germany
22 Apolipoprotein E (ApoE) genotypes and outcome in men and women
patients with cerebral ischemia
M. Baranska, G. Gromadzka, A. Ciesielska, I. Szarzynska-Dlugosz, T. Mendel,
A. Czlonkowska, Department of Neurology, Institute of Psychiatry and
Neurology, Poland
23 Mannitol use in acute stroke and case fatality at 30 days:
an observational study
D. Bereczki, S. Szatmári, L. Mihálka, K. Fekete, V. Smolanka, I. Pascu,
I. Fekete, B. Fülesdi, L. Csiba, University of Debrecen, Hungary

24 Influence of stress-realising neuroimmunoendocrine system on the
course and outcome of acute ischemic stroke
V.I. Skvortsova, I.A. Platonova, E.I. Arsenyeva, I.A. Grivennikov,
Russian State Medical University, Russian Federation
25 Ratio of pro-to anti-inflammatory cytokines at admission predicts
infarct volume and neurological outcome in ischemic stroke
P. Irimia, E. Martínez-Vila, J. Gállego, J. Castillo,
Clínica Universitaria de Navarra, Spain
26 Serum levels of cytokines and adhesion molecules in the acute phase
of ischemic stroke predicts infarct volume but not clinical outcome
P. Irimia, E. Martínez-Vila, J. Gállego, J. Castillo, Clínica Universitaria,
Universidad de Navarra, Spain
27 Outcome in stroke patients with severe dysphagia
G.W. Ickenstein, M. Horn, N. Rallis, R. Goldstein, U. Bogdahn, J. Stein,
University of Regensburg, Germany
28 Association between stroke severity on admission and glycosylated
hemoglobin (HbA1C)
M. Bosnar-Puretic, M. Stojic, V. Vargek-Solter, V. Supanc, V. Demarin,
Sestre Milosrdnice University Hospital, Croatia
29 “Stroke care continuum” – does it influence the outcome after acute
stroke unit treatment?
A. Wiborg, B. Widder, Bezirkskrankenhaus, Department of Neurology and
Neurological Rehabilitation, Germany
30 Prediction of the recovery pattern of auditory comprehension in acute
ischemic stroke using perfusion-weighted CT
K.H. Lee, G.M. Kim, H.H. Kim, S.J. Lee, Y.B. Kim, M.K. Seo, D.L. Na,
C.S. Chung, Samsung Medical Center, Sungkyunkwan University School of
Medicine, South Korea
31 Brainstem infarcton: topography, etiopathogenesis and outcome
E. Vassiliadi, G. Tsivgoulis, K. Spengos, P. Konstantopoulou,
E. Manios, K. Vemmos, University of Athens, Medical School, Greece
71

Poster Sessions Thursday, May 22, 2003
72
32 Prevalence of diabetes mellitus and association with long-term
survival in stroke patients
P. Konstantopoulou, G. Tsivgoulis, K. Spengos, E. Manios, E. Vassiliadi,
V. Kotsis, K. Vemmos, University of Athens, Medical School, Greece
33 Serum cardiac troponin I in acute stroke is related to s-cortisol and
TNF-a
A.H. Christensen, A.F. Christensen, G. Boysen, Bispebjerg Hospital, Denmark
Clinical Neurophysiology
1 What is the angiographic cerebral circulation time?
S. Yamamoto, M. Watanabe, T. Uematsu, K. Takazawa, M. Nukata,
N. Kinoshita, Osaka-Minami National Hospital, Japan
2 Vestibular dysfunctions in anterior inferior cerebellar artery
infarction
H. Lee, H.A. Yi, J. Lee, Y.W. Cho, J.G. Lim, S.D. Yi, Keimyung University
School of Medicine, Dongsan Medical Center, South Korea
3 The control of expiratory muscle function in stroke patients
F. Harraf, W.D. Man, J.F. Rafferty, M.I. Polkey, J. Moxham, L. Kalra, Guy's,
King's & St Thomas' School of Medicine, King's College London,
United Kingdom
4 Neuropsychological findings in asymptomatic carotid artery stenosis
M.D. Mijajlovic, E. Stefanova, N. Sternic, A. Pavlovic, J. Zidverc Trajkovic,
Z. Jovanovic, D.J. Radak, L.J. Ziropadja, V.S. Kostic, Institute of Neurology,
Clinical Center of Serbia, Yugoslavia
Dementia/Higher Cognitive Dysfunction
1 Disability assessment for dementia scale detects mild functional
decline in leukoaraiosis patients. The LADIS (Leukoaraiosis and
DISability) Project
A.M. Basile, L. Pantoni, M. Simoni, G. Pracucci, T. Erkinjuntti, G. Waldemar,
J. Bogousslavsky, D. Inzitari, LADIS Study Group, University of Florence, Italy

2 The cognitive impact of carotid endarterectomy:
benefit and for whom?
C. Greber, T. Karapanayiotides, P. Ruchat, V. Kemeny, B. Piechowski-Jozwiak,
P.A. Despland, J. Bogousslavsky, G. Devuyst, Centre Hospitalier Universitaire
Vaudois, Switzerland
3 The incidence and risk factors for dementia before and after stroke
in Polish hospital-based study
A. Klimkowicz, T. Dziedzic, R. Polczyk, J. Pera, A. Slowik, A. Szczudlik,
Jagiellonian University, Poland
4 Diagnosis of major depression in subcortical vascular
encephalopathy
L. Pantoni, M. Martini, L. Bartolini, M. Lamassa, G. Carlucci, G. Pracucci,
D. Inzitari, Department of Neurological and Psychiatric Sciences,
University of Florence, Italy
5 Reduced N-acetylaspartate/creatine ratio in the frontal lobes of
stroke patients with apathy
L. Glodzik-Sobanska, A. Slowik, P. Szermer, J. Kozub, B. Sobiecka, A. Urbanik,
A. Szczudlik, Institute of Neurology, Jagiellonian University, Poland
6 Vascular lesions in pathological examination:
an international survey
L. Pantoni, V. Palumbo, C. Sarti, I. Alufuzoff, J. Jellinger, D. Munoz, J. Ogata,
Department of Neurological and Psychiatric Sciences, University of Florence,
Italy
Epilepsy and Stroke
1 Epilepsy related to cerebrovascular diseases. Natural history and
outcome
E. Palomeras, P. Fossas, A. Cano, P. Sanz, Hospital de Mataró, Spain
73

Poster Sessions Thursday, May 22, 2003
74
Immunology and Infection in Stroke
1 Neurocysticercosis and subarachnoid hemorrhage (SAH):
infectious or congenital aneurysm?
A.R. Rodríguez-Campello, J.R. Roquer, M.G. Gomis, A.O. Ois, V.P. Puente,
Hospital del Mar, Spain
2 Stroke and chronic HCV infection. Clinical and radiologic analysis
of a series
A. Ponz, R. Chamarro, R. Gil, J.V. López-Mut, J. Soler, J.M. Láinez, Servicio de
Neurología and Unidad de RMN-ERESA, Hospital Clínico Universitario, Spain
IMT Ultrasound
1 Soluble intercellular adhesion molecule-1 is an independent
predictor of the development of carotid atherosclerosis
K. Kondo, K. Kitagawa, H. Hougaku, Y. Nagai, H. Yamagami, T. Hoshi,
H. Hashimoto, M. Matsumoto, M. Hori, Osaka University Graduate School of
Medicine, Japan
2 Clinical significance of posterior communicating artery (P-com)
detected by transcranial Doppler (TCD): correlation with MR
angiography (MRA)
S. Park, E. Song, Y. Lee, College of Medicine, Seoul National University,
South Korea
3 Carotid artery intima-media-thickness as a predictor for cerebral
lacunar infarction
H. Soda, V. Ziegler, S. Schlesinger, D. Steube, B. Griewing, Neurologische
Klinik, Rhön Klinikum, Germany

Genetic Disorders
1 Connection between p53 gene Bam HI RFLP polymorphism and the
volume of brain infarction in patients with carotid atherothrombotic
ischemic stroke
V.I. Skvortsova, P.A. Slominsky, E.A. Koltsova, L.V. Gubsky, I.M. Shetova,
T.I. Tupitsina, I.A. Platonova, S.A. Limborska, Russian State Medical
University, Institute of Molecular Genetics, Russian Federation
2 Polymorphisms of the human ER-alpha gene and ischaemic stroke
J. Cheung, D. St Clair, M.J. MacLeod, University of Aberdeen, United Kingdom
3 Molecular analysis of Notch3 gene in Spanish CADASIL families
I. Ampuero, A. Cervelló, D. Muñoz, D. Mayo, R. San Pablo, C. San Pablo,
B. José, C. Arnal, J. García de Yébenes, J. Hoenicka, Banco de Tejidos para
Investigaciones Neurológicas de Madrid, Spain
4 Plasma homocysteine level, methylenetetrahydrofoliate gene
mutations and risk for ischemic stroke
J. Jakobkiewicz-Banecka, Z. Banecka-Majkutewicz, W.M. Nyka, G. Wegrzyn,
A. Wegrzyn, W. Sawula, B. Banecki, Medical University of Gdansk, Poland
5 Misdiagnosis of Notch3 mutation-positive CADASIL pedigrees in the
West of Scotland
S.S.M. Razvi, R. Davidson, I. Bone, K.W. Muir, Southern General Hospital,
United Kingdom
6 Whole genome search for a candidate locus involved in cervical
artery dissection
C. Grond-Ginsbach, B. Moormann, S. Hyrenbach, T. Wiest, U. Müller,
I. Hausser, O. Busse, T. Brandt, University of Heidelberg, Germany
7 Ischemic stroke: the impact of genetic variants in genes associated
with hypertension
K. Hsieh, W. Lalouschek, S. Greisenegger, D. Haering, M. Reisinger,
M. Janisiw, G. Endler, W. Lang, S. Cheng, C. Mannhalter, AKH Wien,
University Vienna, Austria
75

Poster Sessions Thursday, May 22, 2003
76
8 Vascular risk factors in cerebral autosomal dominant arteriopathy
with subcortical infarcts and leukoencephalopathy (CADASIL):
worthy to think about it
C. Sarti, L. Pantoni, P. Nencini, S. Bianchi, M. Lamassa, A.M. Basile,
R. Kalaria, M.T. Dotti, A. Federico, D. Inzitari, Department of Neurological and
Psychiatric Sciences, University of Florence, Italy
9 Apoe genotype and distribution of cerebral artery atherosclerosis
in patients with stroke
M. Millan, N. Vila, N. Riutort, S. Garcia, X. Ferrer, J.L. Becerra, M. Lozano,
M.C. Pastor, D. Escudero, University Hospital Germans Trias i Pujol, Spain
Interesting Cases
1 Bilateral spontaneous dissection of the internal carotid arteries
A. Spalloni, M. Ferrari, M. Beccia, A. Bracalello, M. Rasura, Policlinico
S. Andrea II, Facoltà di Medicina, Università di Roma "La Sapienza", Italy
2 Five further cases of spontaneous recanalisation during transcranial
Doppler insonation – is this enhanced endogenous thrombolysis?
P. Syme, Borders General Hospital, University of Edinburgh, United Kingdom
3 Reversible cerebral angiopathy: efficacy of intravenous nimodipine
V. Domigo, C. Lamy, V. Rusu, E. Touzé, D. Trystram, M. Zuber, J.L. Mas,
Hôpital Sainte-Anne, France
4 Isolated leptomenigeal amyloid angiopathy presenting as recurrent
subarachnoid cerebral hemorrhage (SAH)
O. Sedlaczek, L. Achtnichts, S. Zoubaa, E. Grips, T. Kinfe, A. Gass,
M.G. Hennerici, Dept. of Neurology Mannheim, University of Heidelberg,
Germany
5 Blue Rubber Bleb Nevus Syndrome (BRBNS)
M. Spitz, A.R. Massaro, S.M.F. Malheiros, H.B. Ferraz, A.A. Gabbai,
Universidade Federal de Sao Paulo, Brazil

6 Bilateral internal carotid artery dissection mimicking
inflammatory-demyelinating disease
C. Lie, S. Schwenk, C. Szabo, O. Lanczik, M.G. Hennerici, A. Gass,
Universitätsklinikum Mannheim, Germany
7 Ischaemic stroke: an uncommon finding of Eales' disease
C.B. De Cock, S.B. Blecic, M. Dagonnier, J. Jacquy, CHU de Charleroi, Belgium
8 Multiple cerebral infarctions during systemic tissue plasminogen
activator (tPA) treatment due to aortic thrombus fragmentation
S.G. Busse, A. Heinrich, A. Hummel, S. Otto, A. Dressel,
University of Greifswald, Germany
9 Ischemic stroke as first manifestation of acute myeloid leukemia
M. Xifaras, I. Markakis, E. Alexiou, M. Vikelis, A. Tsakiris, General Hospital of
Nikea-Pireus, Greece
10 Complex auditory and complex visual hallucinations in two cases of
pontine infarctions
L.C. Álvaro, I. Aranzabal, M.M. Freijo, H. García, J.M. Uterga, F. Sádaba,
Department of Neurology, Basurto Hospital, Spain
11 Spontaneous recanalisation of acute symptomatic internal carotid
artery occlusion
S. Calleja, R. Lopez-Roger, J.M. Llaneza, V. de la Vega, J.M. Gutierrez,
C.H. Lahoz, Hospital Universitario Central de Asturias, Spain
12 Catastrophic antiphospholipid antibody syndrome:
hyperacute evolution from acute abulia to multi-organ-failure
D. Ulbricht, F. Macian, R.J.Metz, Centre Hospitalier de Luxembourg,
Luxemburg
13 Spinal cord ischemia: better outcome than previously thought?
D. Ulbricht, F.M. Huber, F. Macian, R.J. Metz, Centre Hospitalier de
Luxembourg, Luxemburg
14 Subarachnoidal hemorrhage from a venous angioma
A. Lovrencic-Huzjan, Z. Rumboldt, V. Vukovic, V. Demarin,
University Hospital "Sestre milosrdnice", Croatia
77

Poster Sessions Thursday, May 22, 2003
78
15 Transient blurred vision as the only manifestation of basilar stenosis
P. Irimia, J. Sepulcre, M. Moya, C. Barbosa, E. Martínez-Vila,
Clínica Universitaria, Universidad de Navarra, Spain
16 Coexistance of MELAS syndrome and focal segmental
glomerulosclerosis as the clinical phenotype of A3243G point
mutation
S.H. Kim, J. Kim, M.H. Kim, K.Y. Lee, Y.J. Lee, H.T. Kim, Hanyang University,
South Korea
17 Coexistance of MELAS syndrome and focal segmental
glomerulosclerosis as the clincial spectrum of A3243G point
mutation
S. Kim, J. Kim, M.H. Kim, H. Kim, K.Y. Lee, Y.J. Lee, Hanyang University,
South Korea
18 A woman with headache and a prolonged but reversible hemiplegia
M. Langedijk, G.J. Luijckx, J.H. De Keyser, University Hospital Groningen,
The Netherlands
19 Recurrent arterial ischaemic stroke in three successive pregnancies:
a 1-in-1,000,000,000,000 chance?
S.T. Pendlebury, P.M. Rothwell, Stroke Prevention Research Unit,
Department of Clinical Neurology, University of Oxford, United Kingdom

Friday, May 23, 2003
Poster Session II
Chairs: L. Csiba, Hungary, T. Els, Germany, A. Hetzel, Germany and
K. Lees, United Kingdom
Risk Factors and Etiology
1 Metabolic risk factors and carotid intima-media thickness
Y.J. Kim, K.G. Choi, K.D. Park, Korean Metabolic Syndrome Study,
EWHA Womans University, South Korea
2 Genetic variations of the immune system modulate the relation
between acute infections and ischemic cerebrovascular events
W. Lalouschek, G. Endler, K. Hsieh, S. Greisenegger, S. Rieger, W. Lang,
C. Mannhalter, University Clinic of Neurology Vienna, Austria
3 Levels of alpha-1-antitrypsin in plasma and risk of spontaneous
cervical artery dissections: a case-control study
I. Isern, N. Vila, M. Millán, N. Perez de la Ossa, S. Garcia, X. Ferrer, M. Lozano,
N. Riutort, M.C. Pastor, D. Escudero, University Hospital Germans Trías i Pujol,
Spain
4 Mechanisms and etiologies in different vascular territories in young
stroke patients
A. Anziani, M. Beccia, C. Marsiglia, F. Di Lisi, M. Rasura, University of Roma
“La Sapienza”, Italy
5 Clinical characteristics and 90-day outcome of Asian patients with
transient ischeamic attack
R. Esagunde, C. Chen, F. Lateef, H.M. Chang, National Neuroscience Institute,
Singapore General Hospital Campus, Singapore
6 Early risk of recurrent stroke by aetiological subtype: implications for
stroke prevention
J. Lovett, A. Coull, P. Rothwell, Stroke Prevention Research Unit, University
Department of Clinical Neurology, Radcliffe Infirmary, United Kingdom
79

Poster Sessions Friday, May 23, 2003
80
7 The Stroke Prevention in Northumberland Study II (SPIN II):
risk factors for first ever stroke in older people in the UK
J. Greenaway, T. Davies, H. Rodgers, N. Stehen, R. Thomson, R. Wood,
SPIN II Team, University of Newcastle-upon-Tyne, United Kingdom
8 Elevated homocysteine is associated with widespread atherosclerosis
and peripheral artery disease in acute ischaemic stroke patients
A. Sim, G. Ho, D. Neo, S. Tsang, H.H. The, H.M. Chang, A. Auchus,
M.C. Wong, C. Chen, National Neuroscience Institute, Singapore General
Hospital Campus, Singapore
9 POLymorphisms and Risk of Ischemic Stroke (POLARIS) study:
rationale and design
D.M.O. Pruissen, A. Algra, POLARIS Study Group, University Medical Center
Utrecht, The Netherlands
10 Plasma homocysteine level and other vascular risk factors in patients
in acute phase with ischemic stroke
Z. Banecka-Majkutewicz, W.M. Nyka, G. Wegrzyn, W. Sawula,
J. Jakobkiewicz-Banecka, B. Banecki, Medical University of Gdansk, Poland
11 CT angiography in the analysis of patients with stroke in the territory
of the posterior cerebral artery
A. van der Lugt, D. Siepman, C. de Monye, F. Govaere, H. Tanghe, D. Dippel,
Erasmus MC Rotterdam, The Netherlands
12 Are there differences in the risk factor profiles of lacunar and
non-lacunar infarcts? A systematic review
C. Jackson, C. Sudlow, University of Edinburgh, United Kingdom
13 Fall in blood pressure (BP) during 24 first hours stroke onset but not
basal BP is an independent risk factor in progressing stroke
M. Blanco, R. Leira, J. Serena, A. Davalos, J. Castillo, Hospital Clínico
Universitario de Santiago de Compostela, Spain
14 Plasma homocysteine levels in patients with mild or moderate
ischemic stroke
E. Haapaniemi, J. Helenius, L. Soinne, M. Syrjälä, M. Kaste, T. Tatlisumak,
Helsinki University Central Hospital, Finland

15 Factors predictive of and associated with poor prognosis in lacunar
infarctions
J. Castillo, J. Serena, M. Blanco, R. Leira, A. Davalos, Servicios de
Neurología, Hospital Clínico Universitario de Santiago de Compostela, Spain
16 Genetic variation of the intestinal fatty-acid binding protein 2 (FABP2)
gene and the risk of acute cerebrovascular disease. A case-control
study
P. Wanby, P. Palmqvist, L. Brattström, I. Rydén, M. Carlsson, Department of
Internal Medicine, Kalmar County Hospital, Sweden
17 Microhaemorrhages on MR – frequency and association with lacunar
stroke and periventricular white matter hyperintensities
J.M. Wardlaw, G. Alsop, M.S. Dennis, S.L. Keir, University of Edinburgh,
United Kingdom
18 Common polymorphisms of the protein Z gene are negatively
associated with plasma levels and the risk of cerebral ischemia in
the young
C. Lichy, T. Dong-Si, J. Genius, T. Dolan, T. Hampe, S. Kropp, F. Stoll, K. Reuner,
C. Grond-Ginsbach, A. Grau, University of Heidelberg, Germany
19 Differences in the profile of risk factors between nocturnal and
diurnal lacunar strokes
K. Matz, K. Sebek, A. Herrmann, M. Steiner, A. Dachenhausen, M. Brainin,
Center for Postgraduate Studies in Neurosciences, Danube University and
Neurological Department, Donauklinikum Gugging, Austria
20 Hypercholesterolaemia, not hypocholesterolaemia is a risk factor for
spontaneous intracerebral hemorrhage in the Olomouc region,
Czech Republic
R. Herzig, I. Vlachova, J. Mares, B. Krupka, M. Gabrys, H. Vaverkova,
D. Sanak, A. Bartkova, P. Schneiderka, S. Burval, Clinic of Neurology,
Stroke Center, Faculty Hospital, Czech Republic
21 Risk factors and clinical features of sensorimotor stroke
A. Arboix, E. Solà, M. Castillo, M. Oliveres, E. Comes, M. Balcells, C. Targa,
J. Massons, L. García-Eroles, Sagrat Cor Hospital of Barcelona, Spain
81

Poster Sessions Friday, May 23, 2003
82
22 Ethnic differences in markers of thrombophilia – implications for the
investigation of ischaemic stroke in multi-ethnic populations
P. Jerrard-Dunne, A. Evans, R. McGovern, C. Hajat, L. Kalra, A.G. Rudd,
C.D. Wolfe, H.S. Markus, St. Georges Hospital Medical School, United Kingdom
23 Hashimoto-thyreoiditis associated encephalopathy as a risk factor of
ischemic stroke
M. Landgrebe, K. Winbeck, B. Conrad, D. Sander, Technical University of
Munich, Germany
24 Different risks of body mass index for stroke subtypes: a prospective
study in Korean men
S.Y. Song, S.J. Sung, E.S. Ebrahim, Department of Family Medicine, Samsung
Medical Center, Sungkyunkwan University, South Korea
25 Remnant lipoprotein and lipoprotein (A) as risk factors of stroke and
carotid disease
S. Uchiyama, T. Nakamura, K. Miyazaki, Y. Kimura, Y. Tsutsumi, M. Iwata,
Tokyo Women's Medical University, Japan
26 Role of tissue factor in thrombogenecity of advanced carotid
atherosclerotic plaques
E. Catena, J. Krupinski, R. Vila, M. Cairols, F. Rubio, L. Badimon,
Hospital Universitario de Bellvitge, Spain
27 Does the risk factor determine the severity of stroke?
A.D. Kuljic-Obradovic, M. Savic, S. Atic, B. Kulijc, Hospital for Cerebrovacular
Diseases “St. Sava”, Yugoslavia
28 Body fat distribution and prediction of stroke mortality over 23 years
D. Tanne, U. Goldbourt, Sheba Medical Center, Israel
29 Recurrent thromboembolic events and platelet function status in
the patients with antiphospholipid syndrome using aspirin
V.G. Karepov, V. Karataev, Y. Levi, METEOR Medical Center, Internal Medicine,
Medical Center Tel Hashomer, Israel

30 Obstructive sleep apnea syndrome respirator disease during sleep
neurological disease in alertness
V. Mastorodimos, G. Klados, A. Plaitakis, University Hospital of Crete, Greece
31 Aspirin resistance as possible risk factor in stroke occurrence
N. Patsouros, P. Laloux, B. Chatelain, C. Chatelain, Cliniques Universitaires
UCL Mont-Godinne, Service de Neurologie, Service d'Hématologie, Belgium
32 Vascular risk factors for first-ever ischemic stroke in Taiwan:
a hospital-based case-control study
T. Tan, K.C. Chang, M.C. Tseng, C.W. Liou, Chang Gung Memorial Hospital,
Taiwan
33 Recanalisation of cervical artery dissections: influencing factors and
role in neurological outcome
V. Caso, M. Paciaroni, F. Corea, M. Haman, P. Milia, G.P. Pellicioli, L. Parnetti,
V. Gallai, Department of Neuroscience, Italy
34 Serum lipoprotein (a) as an independent marker of the severity of
intracranial large-vessel atherosclerosis. A case-control study
J.F. Arenillas, C.A. Molina, P. Chacon, A. Rovira, J. Montaner, E. Sanchez,
M. Quintana, A. Penalba, J. Alvarez-Sabín, Cerebrovascular Unit,
Department of Neurology, Vall d'Hebron University Hospital, Spain
35 A one year follow-up intracranial asymptomatic arterial stenosis
study
S. Bustos, J. Carneado, J.M. Molto, R. Hernandez, T. Frutos, F. Gracia,
A. Garcia-Escriva, M. Alvarez, J. Matias-Guiu, Hospital General Universitario
Alicante, Spain
36 Hyperhomocysteinemia is an independent risk factor for silent brain
infarcts
A. Byung-Ok Choi, K.G. Choi, K.D. Park, College of Medicine,
Ewha Women’s University, South Korea
37 Snoring: a risk factor for stroke and myocardial infarction
A.A. Roxas, S. Sawit, J. Cabildo, Medical City Hospital, Philippines
83

Poster Sessions Friday, May 23, 2003
84
38 Stroke among inpatients: retrospective analysis of a hospital series
L.C. Álvaro, J. Timiraos, M.M. Freijo, F. Sádaba, C. Cortina, Basurto Hospital,
Spain
39 Association of parental history of stroke with clinical parameters in
patients with ischemic stroke or transient ischemic attack
S. Tentschert, S. Greisenegger, K. Hsieh, W. Lang, W. Lalouschek, Vienna
Stroke Study Group, University Hospital of Vienna, Austria
40 Platelet glycoprotein Ib alfa gene dimorphism Thr145Met is
associated with a risk for stroke due small vessel disease
A. Slowik, D. Partyka, T. Dziedzic, P. Szermer, W. Turaj, L. Sobanska,
A. Dziubek, A. Haefele, D.A. Figlewicz, A. Szczudlik, Collegium Medicium,
Jagiellonian University, Poland
41 Hyperhomocysteinemia and inherited thrombophilic risk factors in
young adults with ischemic stroke
G.B. Boncoraglio, M.R. Carriero, E. Ciceri, E. Ciusani, A. Solari, E.A. Parati,
National Neurological Institute “Carlo Besta”, Italy
42 What is the diagnostic yield between lacunar and territorial
cryptogenic young stroke patients
G.J. Luijckx, S. de Jong, J. Lodder, University Hospital Groningen,
The Netherlands
43 Gender-associated differences in ischemic stroke risk, severity and
outcome: an analysis based on the International Stroke Trial
M. Niewada, A. Kobayashi, S.C. Lewis, P.A.G. Sandercock, A. Czlonkowska,
Warsaw Medical University, Poland
44 Plasma homocysteine level in stroke patients – the Indian experience
A. Rohatgi, S. Bhargava, C.S. Agarwal, L.M. Srivastav, Sir Gangaram Hospital
New Dehli, India
45 Family history of intracranial haemorrhage in adults with a brain
arteriovenous malformation: prospective, population-based study
J.M. Hall, R. Al-Shahi, C.P. Warlow, J.N. Berg, SIVMS Steering Committee,
University of Edinburgh, United Kingdom

46 The -148 C/T fibrinogen polymorphism and fibrinogen levels in
patients with ischemic stroke. A case-control study
D.W. Dippel, M.P. van Goor, G.J. Brouwers, E.B. Gomez Garcia, P.J. Koudstaal,
F.W. Leebeek, Erasmus Medical Center, The Netherlands
47 The plasminogen-activator inhibitor type 1 (PAI-1) 4G/5G promotor
polymorphism and PAI-1 levels in patient with ischemic stroke.
A case-control study
D.W. Dippel, M.P. van Goor, G.J. Brouwers, E.B. Gomez Garcia, P.J. Koudstaal,
F.W. Leebeek, Erasmus Medical Center, The Netherlands
48 Isolated cerebral vasculitis. A disease frequently misdiagnosed as
recurrent cryptogenic strokes
K.H. Pedersen, S.M. Jeangette, N. Mavroudakis, M. Pandolfo, S.A. Blecic,
Erasme Hospital, Belgium
49 Marburg I polymorphism of factor VII activating protease.
A prominent risk predictor of carotid stenosis
S. Kiechl, J. Willeit, T. Weimer, A. Mair, P. Santer, C.J. Wiedermann,
J. Roemisch, University Clinic Innsbruck, Austria
50 Mild, moderate and severe carotid stenosis: relation to
cardiovascular risk factors in patients with acute ischemic stroke
A. Chrysanthopoulou, G. Gioldasis, G. Terzis, A. Kalogeropoulos,
T. Papapetropoulos, University Hospital Patras, Greece
51 Reduced levels of plasma EC-SOD, a protector against oxidative
stress, in acute stroke patients
P.G. Wiklund, S.L. Marklund, P. Nilsson, K. Asplund, Dept. of Public Health
and Clinical Medicine, Umeå University, Sweden
52 Ischemic stroke and hyperhomocysteinemia: lack of guidelines for
management
A.L. Rebocho, I. Henriques, L. Domingues, M. Graca, Hospital Espirito Santo,
Portugal
53 Platelet-leukocyte interaction and platelet activation in migraine.
A link to ischemic stroke?
J.A. Zeller, K. Frahm, R. Stingele, G. Deuschl, Christian-Albrechts University
Kiel, Germany
85

Poster Sessions Friday, May 23, 2003
86
54 Increased platelet-leucocyte aggregation in patients with acute
ischemic stroke
J.A. Zeller, A. Lenz, R. Stingele, G. Deuschl, Christian-Albrechts University
Kiel, Germany
55 Does smokeless tobacco increase the risk of stroke?
K. Asplund, S. Nasic, U. Janlert, B. Stegmayr, Department of Public Health
and Clinical Medicine, Sweden
Neuroimaging: MRI and fMRI
1 Evidence of vicarious function for the human motor cortex:
a longitudinal fMRI study after primary motor area stroke
A. Jaillard, C. Delon Martin, K. Garambois, J.F. Lebas, M. Hommel,
Universitary Hospital of Grenoble, France
2 Transient global amnesia with hippocampal ischemic lesions –
a report of two cases
P. Kapeller, S. Horner, B. Melisch, K. Petrovic, C. Enzinger, E. Ott, F. Fazekas,
Karl Franzens University Graz and MRI Centre, Austria
3 Intra-arterial high signal on fluid attenuated inversion recovery
images (IHS-FLAIR) in acute ischemic stroke on MCA territory
B.C. Lee, J.S. Bae, K.H. Yu, J. Seung-Cheol, M. Hyeo-il, Hallym University
College of Medicine, South Korea
4 Withdrawn by author
5 Clinical significance of dominant ipsilateral posterior cerebral artery
on magnetic resonance angiography in acute ischemic stroke
J.H. Lee, S.J. Han, W.Y. Kang, K.H. Lee, I.S. Choi, K.H. Yu, H.K. Song,
College of Medicine, Hallym University, South Korea
6 Infarct growth in acute stroke predicted by MR perfusion and
diffusion weighted imaging
F. Schneider, A.C. Januel, L. Court, P. Garnier, M. Homel, A. Jaillard,
S. Laporte, A. Viallon, D. Michel, F.G. Barral, CHU de Saint Etienne, France

7 Relationship of the Apparent Diffusion Coefficient (ADC) decrease
with penumbra and infarct core as defined by PET in acute ischaemic
stroke
J. Guadagno, E. Warburton, T. Fryer, F. Aighuiro, C. Price, S. Harding, J. Gillard,
J. Clark, A. Carpenter, J.C. Baron, Cambridge University, Dept. of Neurology
and Stroke, Wolfson Brain Imaging Centre, United Kingdom
8 Validity and reliability of flair technique measuring cerebral infarct
volumes
S. Pedraza, C. Guergue, J. Mendez, J. Vera, Y. Silva, A. Davalos,
Hospital Josep Trueta, Spain
9 Evaluation of interscanner variability of ADC data acquisition in
stroke centres in Germany
C. Lie, J. Hirsch, T. Kucinski, J. Junge-Huelsing, M. Siebler, C. Fitzek,
S. Heiland, A. Roether, A. Villringer, A. Gass, M.G. Hennerici,
Universitätsklinikum Mannheim, Germany
10 Perfusion computed tomography and CT angiography in the early
assessment of acute ischemic stroke
J.M. Esteban, V. Cervera, F.M. Gurrea, O. Velez, C. Guillen, ERESA,
Hospital General Universitario de Valencia, Spain
11 “Fogging” on MR after ischaemic stroke – how often does it occur
and does it matter?
A.P. O'Brien, S. Stretton, R.J. Sellar, J.M. Wardlaw, University of Edinburgh,
United Kingdom
12 The effect of ischaemic lesion swelling on serial MR diffusion and
perfusion measurements in stroke
A.C.S. Rivers, P.A. Armitage, T. Carpenter, M.E. Bastin, P.J. Hand, M.S. Dennis,
J.M. Wardlaw, University of Edinburgh, United Kingdom
87

Poster Sessions Friday, May 23, 2003
88
13 Comparison of clinical and neuroradiological characteristics
between internal carotid artery and middle cerebral artery disease
P.H. Lee, S.H. Oh, O.Y. Bang, I.S. Joo, K. Huh, College of Medicine,
Ajou University, South Korea
14 Comparison of clinical and neuroradiological characteristics
between internal carotid artery and middle cerebral artery diseases
P. Lee, S. Oh, O. Bang, I. Joo, K. Huh, College of Medicine, Ajou University,
South Korea
15 MR perfusion imaging: problems resulting from a lack of contrast
agent in infarcted regions
P.A. Armitage, C.S. Rivers, T.K. Carpenter, M.E. Bastin, P.J. Hand,
J.M. Wardlaw, University of Edinburgh, United Kingdom
16 Artefacts in MR perfusion parametric images in ischaemic stroke –
effects of variation in bolus arrival time
T.K. Carpenter, P.A. Armitage, M.E. Bastin, J.M. Wardlaw, University
Edinburgh, United Kingdom
17 Neuro-Behcet’s disease: a clinical and MRI study
N.M. El-Nahas, H.M. Abdel Kader, Ain Shams University, Egypt
18 Improved detection of brainstem infarctions in the first 24 hours using
diffusion-weighted imaging with an optimised spatial resolution
T. Etgen, H. Gräfin von Einsiedel, K. Winbeck, B. Conrad, D. Sander,
Technical University Munich, Germany
19 False-negative diffusion-weighted MR images in hyperacute
ischemic stroke
M.W. Masaki Watanabe, K.I. Keisuke Imai, T.M. Takahisa Mori, T.K. Toshiki
Kamiya, H.I. Hajime Izumoto, Shonan Kamakura General Hospital, Japan
20 Multislice CT angiography for investigation of vertebrobasilar
ischaemia
S.S.M. Razvi, E. Teasdale, C. Santosh, I. Bone, K.W. Muir, Southern General
Hospital, United Kingdom

21 Calcification of intracranial arteries on CT as a marker of
atherosclerosis in stroke patients
N.C. Suwanwela, N. Suwanwela, Chulalongkorn University, Thailand
22 Intracerebral haemorrhage on warfarin at the site of a known
microhaemorrhage on T2* MR imaging – a case report
S.R. Hart, J.M. Wardlaw, A.J. Farrall, P.A. Sandercock, M.S. Dennis,
Dept. of Clinical Neuroscience, University of Edinburgh, United Kingdom
23 Cerebral ischemic lesions after unprotected stenting or
entarterectomy in symptomatic proximal internal carotid stenosis:
a prospective diffusion-weighted MRI study
S. Garcia, J. Capellades, J. Muchart, J. Callejas, N. Vila, X. Ferrer,
J.M. Michavila, M. Lozano, D. Escudero, University Hospital Germans
Trias i Pujol, Spain
24 Noninvasive quantitative assessment of Cerebral Blood Flow (CBF)
using 99mTc-ECD SPECT with adjunctive radionuclide angiography in
ischemic stroke
S.H. Kim, J. Kim, M. Kim, H. Kim, Y.Y. Choi, Hanyang University, South Korea
25 Early wallerian degeneration of the pyramidal tract after ischemic
stroke: a diffusion tensor imaging study
G. Thomalla, V. Glauche, C. Weiller, J. Röther, Klinik und Poliklinik für
Neurologie, Universitätsklinikum Hamburg-Eppendorf, Germany
26 Utility of CT perfusion scan in the diagnosis of acute ischemic stroke:
experience in 47 patients
J.M. Esteban, V. Cervera, I. Puchades, S. Roch, V. Ballester, J. Casañ,
ERESA, Hospital General Universitario de Valencia, Spain
27 Cerebral blood flow reduction correlates with CT density decrease in
acute stroke patients
T. Kucinski, A. Majumder, R. Knaab, D. Naumann, J. Fiehler, O. Vaeterlein,
B. Eckert, J. Roether, H. Zeumer, University Hospital Hamburg-Eppendorf,
Germany
89

Poster Sessions Friday, May 23, 2003
90
28 Clinicoradiologic findings of spinal cord injury in decompression
sickness
J.Y. Ahn, M. Kim, J.Y. Kim, Gangnam General Hospital Public Corporation,
South Korea
29 Microbleeding prevalence. Analysis by stroke subtype
R. Gil Gimeno, A. Ponz, R. Chamarro, J.M. Santonja, J.V. López Mut,
J.M. Láinez, Hospital Clínico Universitario de Valencia, Spain
30 Transient decreased activation in lacunar strokes:
a longitudinal fMRI study
K. Garambois, A. Jaillard, C. Delon Martin, J.F. Lebas, M. Hommel,
Universitary Hospital of Grenoble, France
31 Age-related neural correlates during a finger-tapping task in normal
subjects: a fMRI study
A. Jaillard, K. Garambois, C. Delon Martin, J.F. Lebas, M. Hommel,
Universitary Hospital of Grenoble, France
Recovery and Rehabilitation
1 The effects of an individualised information booklet in post stroke
patients: the care file project
D. Lowe, M. Leathley, A. Sharma, University Hospital Aintree, United Kingdom
2 IMPACCTS – Improving Patient And Carer Communication, Team
working and goal Setting – in stroke rehabilitation
J. Monaghan, A.K. Sharma, D. McDowell, Stroke Team for Audit and
Research, University Hospital Aintree, United Kingdom
3 A case for improved post-stroke follow-up
L.N. Smith, M.I. Lawrence, S.M. Kerr, P. Langhorne,
K.R. Lees, University of Glasgow, United Kingdom
4 Early supported discharge services for stroke patients:
an individual patient data meta-analysis
P. Langhorne, Early Supported Discharge Trialists, Academic Section of
Geriatric Medicine, University of Glasgow, United Kingdom

5 Augmented physiotherapy after stroke: a randomised controlled trial
P. Langhorne, Glasgow Augmented Physiotherapy after Stroke (GAPS) Study
Group, Academic Section of Geriatric Medicine, University of Glasgow,
United Kingdom
6 National audit of stroke secondary prevention in the United Kingdom
A.G. Rudd, A. Hoffman, D. Lowe, P. Irwin, M. Pearson, Royal College of
Physicians London, United Kingdom
7 Development of a comprehensive description of hands-on therapy
for the hemiplegic upper limb and a treatment schedule to record
individual treatments
S.M. Hunter, P. Crome, J. Sim, V.M. Pomeroy, Keele University,
United Kingdom
8 Community stroke groups for patients with aphasia after stroke:
users views of criteria for effectiveness
L.A. Legg, D. Clark, Glasgow University, United Kingdom
9 Bilateral paramedian thalamic infarcts. Evolution in six cases
F. Macian, L. Magy, C. Chastagner, M. Khalil, J.M. Vallat,
CHRU Dupuytren, France
10 Social effects on patients after a stroke incident (SI)
P. Heras, A. Argyriou, S. Karagiannis, M. Corcondilas, D. Mitsibounas,
General Hospital of Kos, Greece
11 Biological factors associated with late post-stroke depression:
preliminary results of a case-control study
K. Chatterjee, D.H. Barer, Stroke Research Unit, Queen Elizabeth Hospital,
United Kingdom
12 Faecal incontinence after stroke varies with time from onset and
stroke sub-type
J.A. Barrett, H. Pandya, V. Little, P. Weir, M.E. Barrett, G. Sangster, R. Plant,
M. Pritchard Howarth, C. Jack, C.L. Watkins, Wirral Stroke Service,
United Kingdom
91

Poster Sessions Friday, May 23, 2003
92
Management/Economics
1 An urban stroke project – enhancing logistics to treat more patients
with rtPA faster
M. Fritzinger, O. Mielke, M. Daffertshofer, M.G. Hennerici, Dept. of Neurology
Mannheim, University of Heidelberg, Germany
2 A pilot evaluation of a new secondary prevention intervention:
lessons for current practice
J. Redfern, C. McKevitt, A. Rudd, C. Wolfe, King's College London,
United Kingdom
3 Medical resource use and costs of patients with acute stroke during
twelve months after acute hospital stay
K. Rossnagel, J. Müller-Nordhorn, D. Menke, C.H. Nolte, G.J. Jungehuelsing,
A. Reich, A. Villringer, S.N. Willich, Institute of Social Medicine, Epidemiology
and Health Economics, Charité, Germany
4 Stroke unit vs. general neurology ward. A diagnosis related group
based study
J. Matías-Guiu, J. Aranaz-Andrés, F. Gracia-Fleta, J. Carneado-Ruiz,
J. Hernández-Lorido, H.M. Moltó-Jordà, Hospital General Universitari
d'Alacant, Spain
5 The cost of secondary stroke in Poland
M. Niewada, B. Kaminski, A. Kobayashi, A. Czlonkowska, A. Czlonkowski,
Department of Experimental and Clinical Pharmacology, Warsaw Medical
University, Poland
6 Management of acute stroke across Germany: results from the
German Stroke Registries Study Group (ADSR)
P.L. Kolominsky-Rabas, P.U. Heuschmann, B. Misselwitz, A. Haass,
K. Lowitzsch, B. Neundoerfer, K. Berger, Public Health Medicine Research
Unit, University of Erlangen, Germany
7 Medical management of cervical arterial dissections:
a study of routine practice in France
F. Vuillier, L. Tatu, T. Moulin, CHU Besançon, France

8 Costs of acute care of first-ever ischemic stroke in Taiwan
K.C. Chang, M.C. Tseng, Chang Gung Memorial Hospital, Taiwan
9 Resource utilisation and costs of stroke unit care in Germany
A.E. Spottke, C. Haacke, K. Zamzow, S. Pawelzik, M. Rethfeldt, W.H. Oertel,
O. Schöffski, R.C. Dodel, T. Back, University Bonn and University Marburg,
Germany
10 Improving trials in acute stroke using internet randomisation and data
collection
P.M. Bath, S. Yeung, G. Watson, C.S. Weaver, University of Nottingham,
United Kingdom
11 Ischemic stroke patients with previous TIA: special patients?
R. Pires, I. Henriques, S. Pires-Barata, L. Rebocho, Hospital Espirito Santo
Evora, Portugal
12 Epidemiology of stroke in Martinique, French West Indies
(ERMANCIA study): an assessment of the secondary prevention
3.5 years following a first-ever stroke
D. Smadja, S. Olindo, P. Cabre, P. René-Corail, E. Hars, M. Saint-vil,
University Hospital of Fort-de-France-La Meynard, Martinique
13 Alternative strategies for stroke care: cost-effectiveness analysis
from a prospective randomised controlled trial
A. Patel, M. Knapp, I. Perez, A. Evans, L. Kalra, Guy's, King's and St Thomas'
School of Medicine, King's College London, United Kingdom
Experimental Studies
1 Efficacy of 340 kHz pulsed ultrasound as acute stroke therapy in a rat
model of embolic stroke
M. Fatar, M. Stroick, M.G. Hennerici, M. Daffertshofer, Dept. of Neurology,
Klinikum Mannheim, University of Heidelberg, Germany
2 Evidence for vascular leakage in the photothrombotic model for stroke
E. Hoff, M. OudeEgbrink, V. Heijnen, R. van Oostenbrugge,
University Maastricht, The Netherlands
93

Poster Sessions Friday, May 23, 2003
94
3 Lipid peroxidation and ischemic brain disease
D. Veljancic, R. Raicevic, P. Jovic, T. Lepic, E. Dincic, Military Medical
Academy, Yugoslavia
4 Dose-dependent, neuroprotective effects of citicoline in an
experimental model of brain ischaemia
I. Lizasoain, O. Hurtado, A. Davalos, R. Lozano, J.J. Secades, J. Cleza,
P. Lorenzo, M.A. Moro, J. Castillo, Universidad Complutense Madrid, Spain
5 Histopathological correlates of MR diffusion and perfusion imaging in
animal stroke models
A.C.S. Rivers, J.M. Wardlaw, University of Edinburgh, United Kingdom
6 In vitro ischemic preconditioning produces neuroprotection which is
mediated by up-regulation of glutamate uptake
M.A. Moro, C. Romera, S.H. Botella, O. Hurtado, A. Cárdenas, J.C. Leza,
P. Lorenzo, P. Fernández-Tomé, I. Lizasoain, Departamento de Farmacología,
Universidad Complutense de Madrid, Spain
7 Changes of ceramide level in the rat brain under chronic cerebral
hypoperfusion: biochemical and immunohistochemical study
R. Ohtani, H. Tomimoto, H. Wakita, T. Kondo, M. Watanabe, T. Taguchi,
I. Akiguchi, T. Okazaki, H. Shibasaki, Kyoto University Graduate School of
Medicine, Japan
8 Effects of anti-thrombotic agents on hemorheology in a
microcirculation model
Y. Kimura, S. Uchiyama, Y. Piao, M. Iwata, Neurological Institute,
Tokyo Women’s Medical University, Japan
9 Subacute immobilisation stress increases infarct volume after
permanent focal cerebral ischemia in rats
J.C. Leza, J.R. Caso, J.L. Madrigal, B. Garcia-Bueno, M.A. Moro, I. Lizasoain,
P. Lorenzo, Departamento Farmacologia, Universidad Complutense Madrid,
Spain

10 Inhibition of glutamate release accounts for neuroprotective effects
of tocopherol in experimental stroke
M.A. Moro, M.P. Pereira, A. Cardenas, O. Hurtado, J.L. Madrigal,
J.C. Leza, P. Lorenzo, I. Lizasoain, Departamento Farmacologia,
Universidad Complutense Madrid, Spain
11 In vivo ischemic preconditioning involves up-regulation of TNF
receptor I
I. Lizasoain, J.M. Pradillo, M.P. Pereira, A. Cardenas, J.C. Leza, M.A. Moro,
P. Lorenzo, A. Davalos, J. Castillo, Departamento Farmacologia,
Universidad Complutense Madrid, Spain
12 Evaluation of ischemia induced selective gene expression by
measure of FAS receptor RNA levels in rat brain
M. Alonso de Leciñana, M. Gutierrez, E. Díez-Tejedor, P. Santos, S. Calvo,
M. Sobrado, V. Ceña, Cerebrovascular Research Unit, Hospital La Paz and
Hospital N Sra de Sonsoles, Spain
13 A protease resistant peptide inhibitor of C-JUN N-terminal kinase
provides very strong protection against focal cerebral ischemia
L. Hirt, T. Borsello, P.G.H. Clarke, A. Vercelli, M. Repici, D.F. Schorderet,
J. Bogousslavsky, C. Bonny, Centre Hospitalier Universitaire Vaudois,
Switzerland
14 Early hyperbaric oxygenation rescues neurons in penumbra and
striatum from ischemic cell death in transient cerebral ischemia in
the rat
C.C. Eschenfelder, M. Lou, T. Herdegen, G. Deuschl, Christian-Albrechts
University, Germany
95

Poster Sessions Friday, May 23, 2003
96
Neurosurgery/Vascular Surgery
1 Emotional, cognitive, and neurologic status after carotid surgery
A. Faulstich, P. Marx, B. Mann, A. Hartmann, University Hospital Benjamin
Franklin, Free University Berlin, Germany
2 A grading system for intracranial artereovenous malformations
applicable to endovascular procedures
B.Y. Sheikh, King Faisal University Hospital, Saudi Arabia
3 Extracranial carotid angioplasty and stenting in contralateral
high-degree carotid stenosis or occlusion symptomatic patients
R. González-Santiago, F. Nombela, M. Tamayo, J. Vivancos,
Hospital Universitario De La Princesa, Spain
4 Carotid stenting: our experiencies
B. Zvan, Z. Milosevic, I. Kocijancic, M. Zaletel, University Medical Centre
Ljubljana, Slovenia
5 Carotid angioplasty in patients older than 80:
acute and subacute results
K. Rabe, H. Goedel, R. Perron, I. Boesenberg, K.F. Beykirch, R. Theis, C. Rubel,
W. Pfeil, H. Sievert, Cardiovascular Center Bethanien, Germany
6 Unruptured aneurysms: endovascular treatment.
Experience of 68 cases
J. Izquierdo, E. Vivas, L. Soler, T. Sola, E. Balaguer, L. Guimaraens,
Hospital General de Catalunya, Spain
7 Endovascular treatment in ruptured aneurysms experience in 145 cases
E. Vivas, T. Sola, L. Soler, E. Balaguer, J. Izquierdo, L. Guimaraens,
Hospital General de Catalunya, Spain
8 Anterior circulation large and giant aneurysms: surgical and
endovascular techniques, complications and clinical outcomes
C. Todaro, E. Ciceri, P. Ferroli, C. Marras, A. Franzini, M. Carriero,
G. Boncoraglio, E. Parati, S. Giombini, G. Broggi, Istituto Nazionale
Neurologico “Carlo Besta”, Italy

Cerebral Haemorrhage and SAH
1 Prognostic factors of intracerebral haemorrhage in patients with
previous TIA or ischaemic stroke
M.J. Ariesen, A. Algra, P.M. Rothwell, Cerebrovascular Cohort Studies
Collaboration, University Medical Centre Utrecht, Julius Centre for Health
Sciences and Primary Care, The Netherlands
2 Acute hyperglycemia and outcome after subarachnoid hemorrhage
S. Dorhout Mees, G. van Dijk, A. Algra, D. Kempink, R. Gabriel,
University Medical Center Utrecht, The Netherlands
3 Acute hydrocephalus in subarachnoid hemorrhage:
outcome and complications of treatment
I.S. Beijer, G.W. van Dijk, A. Algra, G.J.E. Rinkel, University Medical Center
Utrecht, The Netherlands
4 Von Willebrand factor as predictor for intracerebral hemorrhage.
A prospective incident case-referent study
L. Johansson, J.H. Jansson, B. Stegmayr, T.K. Nilsson, G. Hallmans, K. Boman,
Department of Public Health and Clinical Medicine, Umeå University Hospital,
Sweden
5 The additional risk of uncontrolled hypertension for intracerebral
hemorrhage in hypertensive patients. A post-mortem, case-control
study
M.A. Ritter, R. Szepesi, K. Hegedüs, D.W. Droste, E.B. Ringelstein, L. Csiba,
UKM Münster, Germany
6 Genetic polymorphisms and outcome after aneurysmal subarachnoid
hemorrhage
Y.M. Ruigrok, A.J. Slooter, A. Bardoel, C.J. Frijns, C. Wijmenga, G.J.Rinkel,
University Medical Center Utrecht, The Netherlands
7 Late recurrent subarachnoid hemorrhage:
patient characteristics and outcome
M.J.H. Wermer, G.J.E. Rinkel, P. Greebe, K.W. Albrecht, C.M. Dirven,
C.A. Tulleken, University Medical Centre Utrecht / Rudolf Magnus Institute for
Neurosciences, The Netherlands
97

Poster Sessions Friday, May 23, 2003
98
8 Long-term functional outcome after aneurysmal subarachnoid
haemorrhage
G.J.E. Rinkel, P. Greebe, A. Algra, Rudolf Magnus Institute of Neuroscience,
University Medical Centre Utrecht, The Netherlands
9 Infratentorial location is an independent determinant for hemorrhagic
presentation of brain arteriovenous malformations (AVMs)
A.V. Khaw, J.P. Mohr, R.R. Sciacca, H.C. Schumacher, J. Pile-Spellman,
H. Mast, C. Stapf, Columbia University College of Physicians and Surgeons,
USA
10 Delirium in acute subaracnoid haemorrhage
L. Caeiro, J.M. Ferro, R. Albuquerque, M.L. Figueira, Hospital Santa Maria,
Portugal
Venous Diseases
1 Cerebellar venous infarction: two case reports
S. Calado, J. Graça, I. Palma, C. Ribeiro, M. Viana-Baptista,
Hospital Egas Moniz, Portugal
2 Aseptic cerebral venous thrombosis: a perspective study in an
university hospital in Thailand
K. Phanthumchinda, S. Wanichapol, I. Thaipisuttikul, N.C. Suwanwela,
Faculty of Medicine, Chulalongkorn University, Thailand
3 Third occurrence of cerebral venous thrombosis in a 33-year old
woman
N. Amberger, M. Weih, L. Harms, J. Valdueza, Charité Hospital,
Humboldt University, Germany
4 Seizures after Cerebral Venous Thrombosis (CVT)
A.P. Dutra, E.C. Sa de Camargo, A.R. Massaro, L.A. Bacheschi, M. Scaff,
Universidade de Sao Paulo, Brazil
5 Infarction of spinal cord and pure bilateral brachial paresis
G. Sampaio Silva, A.R. Massaro, R. de Lima Carvalho, L. Azevedo, A.J. Santos,
H.B. Ferraz, A.A. Gabbai, Universidade Federal de Sao Paulo, Brazil

6 Delay in hospital admission of patients with cerebral vein and dural
sinus thrombosis
J.M. Ferro, M.G. Lopes, M.J. Rosas, F. Pita, J. Fontes, VENOPORT Investigators,
Hospital Santa Maria, Portugal
7 Headache in early diagnosis of cerebral venous thrombosis:
clinical experience in 59 patients
S. Iurlaro, A. Ciccone, E. Beghi, A. Gatti, G. Bussone, M. Leone, A. Rigamonti,
P. Santoro, C. Ferrarese, E. Agostani, Neurology Milano-Bicocca University,
San Gerardo Hospital, Niguarda Hospital, C. Besta Institute, Italy
8 Are D-dimer useful in the diagnostic strategy of cerebral venous
thrombosis?
R.F. Sztajzel, P.H. Lalive, P. de Moerloose, K. Lovblad, F. Sarasin,
University Hospital Geneva, Switzerland
9 Isolated headache as the only manifestation of the cerebral venous
thrombosis
A.R. Cumurciuc, I. Crassard, M. Sarov, D. Valade, M.G. Bousser,
Lariboisiere Hospital Paris, France
Meta-Analysis and Review Papers
1 What do qualitative studies of stroke tell us? A literature review
C. McKevitt, J. Redfern, F. Mold, C. Wolfe, King's College London,
United Kingdom
2 Risk of severe intracerebral haemorrhage after rt-PA for ischaemic
stroke in patients with extended ischaemic changes on computed
tomography
V. Larrue, V. Lauwers-Cances, University of Toulouse, France
3 Brain displacement in patients with TND due to CSH
H.G. Sunku, Hinchingbrooke Hospital, United Kingdom
99

Poster Sessions Friday, May 23, 2003
100
4 Optimising the statistical analysis of functional outcome in stroke trials
P.M. Bath, Optimising Analysis of Stroke Trials (OAST) Collaborators,
University of Nottingham, United Kingdom
5 A systematic review of Terson syndrome:
frequency and prognosis in subarachnoid haemorrhage
M.O. McCarron, P.G. McCarron, Royal Victoria Hospital, United Kingdom
6 Medial medullar infarction: clinical manifestations and magnetic
resonance imaging findings
K. Chung, S.M. Lee, S.S. Yoon, D.I. Chang, College of Medicine,
Kyung Hee University, South Korea
Cardiac Disorders and Stroke
1 Detection of cardioembolic dysrythmia using long-term ECG
recording after acute stroke
D. Jabaudon, K. Sievert, H. Sunthorn, J. Sztajzel, R. Sztajzel,
Hôpitaux Universitaires de Genève, Switzerland
2 Aortic arch dissection in potential thrombolysis candidates
M. Bruandet, S. Crozier, M. Obadia, C. Lefevre, A. Chevrel,
Y. Samson, Hôpital de la Salpétrière, France
3 Transcranial Doppler (TCD) in patients with refractory congestive
heart failure (CHF) before and after heart transplantation
S. Malheiros, A.R. Massaro, D.R. Almeida, A.P. Dutra, R.B. Diniz, J.N. Branco,
A.A. Gabbai, Universidade Federal de Sao Paulo, Brazil
4 Cerebral microembolism during transmyocardial laser
revascularisation and strategies for its avoidance
T. Gerriets, M. Grossherr, M. Misfeld, U. Nees, E. Reusche, E. Stolz,
H.H. Sievers, M. Kaps, E.G. Kraatz, University Giessen and University Lübeck,
Germany
5 Interleukin-6 regulates acute phase reaction in ischemic stroke
T. Dziedzic, A. Klimkowicz, A. Slowik, A. Szczudlik, Jagiellonian University,
Poland

New Clinical Trial Results
1 Is the intervention of an occupational therapist effective in increasing
independence for residents with stroke living in a care home?
C. Sackley, D.T. Wade, D. Mant, University of Oxford, United Kingdom
2 SAFE II Study: why anticoagulants still remain underused in Europe?
Part 2–A survey from neurologists’ practices after stroke
D. Deplanque, J.L. Mas, V. Gallai, J. Ferro, J. de Reuck, R. Schmidt,
D. Parnetti, D. Leys, SAFE II Investigators, Neurology and Pharmacology
Departments, CHRU de Lille, France
3 Therapeutic benefit of abciximab in acute ischemic stroke as
measured by modified Rankin Scale (mRS) responder analysis
W. Hacke, Universitatsklinikum Heidelberg, Germany
4 The effects of three antiplatelet drugs given singly or together on
platelet and leucocyte function in healthy subjects and patients with
previous ischaemic stroke
L. Zhao, S. Fletcher, C. Weaver, J. Leonardi-Bee, J. May, S. Fox, S. Heptinstall,
P.M.W. Bath, Centre for Vascular Research, University of Nottingham,
United Kingdom
5 Effects of simvastatin on the progression of white matter changes:
a post-hoc analysis of a randomised, boubled-blind,
placebo-controlled study
K.S. Wong, Y.H. Fan, W.W.M. Lam, T.H. Tsoi, P.W. Ng, ROCAS Study Group,
Chinese University of Hong Kong, Hong Kong
6 Timing of recanalisation and risk of symptomatic intracranial
hemorrhage after iv tPA. The CLOTBUST Collaboration Study Group
C.A. Molina, A.M. Demchuk, M. Saqqur, J.F. Arenillas, J. Montaner,
J. Alvarez-Sabin, A.V. Alexandrov, CLOTBUST Collaboration Study Group,
Hospital Vall d´Hebron, Spain
7 Differential suppression of thromboxane biosynthesis by indobufen
and ASA in patients with ischaemic stroke
S. Ricci, E. Ricciotti, M.G. Celani, E. Righetti, E. Stragliotto, F. Stracci,
P. Patrignani, Stroke Service Perugia, Italy
101

Poster Sessions Friday, May 23, 2003
102
Ongoing Trials
1 The VITATOPS (VITAmins To Prevent Stroke) Trial
G. Hankey, VITATOPS Trial Collaborative Group, Royal Perth Hospital, Australia
2 The Continue Or Stop post-Stroke Antihypertensives Collaborative
Study (COSSACS)
T.G. Robinson, J.F. Potter, COSSAC Study Group, Leicester Warwick Medical
School, United Kingdom
3 Acute Cerebral CT Evaluation Stroke Study (ACCESS)
A.J. Farrall, O. Mielke, R. von Kummer, P. Chmielnik, D. Perry, J.M. Wardlaw,
Division of Clinical Neurosciences, University of Edinburgh, United Kingdom
4 HAMLET Hemicraniectomy After MCA infarction with Life-threatening
Edema Trial
J. Hofmeijer, H.B. van derWorp, G.J. Amelink, A. Algra, J. van Gijn,
L.J. Kappelle, Department of Neurology, UMCU, The Netherlands
5 The Third International Stroke Trial (IST-3)
P. Sandercock, R. Lindley, The Third International Stroke Trial (IST-3)
Collaborative Group, University of Edinburgh,
Department of Clinical Neuroscience, United Kingdom
6 Does surface neuromuscular electrical stimulation (sNMES) to the
upper limb following acute stroke improve outcome?
C. Church, R. Curless, S. Huntley, C. Price, D. Pandyan, H. Rodgers,
Departments of Geriatric Medicine, Northumbria Health Care Trust and
University of Newcastle upon Tyne, United Kingdom
7 Stop Stroke. A new intervention to improve stroke secondary
prevention
J. Redfern, C. McKevitt, A. Rudd, C. Wolfe, King's College London,
United Kingdom
8 Thrombolytic therapy for acute ischemic stroke: the SYNTHESIS trial
A. Ciccone, E. Boccardi, C. Coppola, A. Gatti, A. Guccione, I. Santilli,
L. Valvassori, Dept. of Neurosciences, A.O. Niguarda Ca' Granda, Italy

9 Controlling Hypertension and Hypotension Immediately Post-Stroke
(CHHIPS) Trial
T.G. Robinson, J.F. Potter, G.A. Ford, CHHIPS Trial Group, Leicester Warwick
Medical School, United Kingdom
10 The Ongoing Telmisartan Alone and in combination with Ramipril
Global Endpoint Trial (ONTARGET) in 25,000 patients at high risk of
stroke and cardiovascular disease: recruitment update
A.C.S. Anderson, University of Auckland, New Zealand
11 ESPRIT: mild anticoagulation, acetylsalicylic acid plus dipyridamole
or acetylsalicylic acid alone after cerebral ischemia of arterial origin
E. De Schryver, C. Ferrier, ESPRIT Study Group, University Medical Center
Utrecht, The Netherlands
12 Magnesium and Acetylsalicylic Acid in Subarachnoid Hemorrhage
(MASH), a prospective randomised, placebo-controlled, multicenter
trial
W. van den Bergh, G. Rinkel, MASH Study Group, Department of
Neurosurgery, University Medical Centre Utrecht, The Netherlands
13 Clinical value of motor imagery and bodyweight supported treadmill
training for recovery of gait performance of stroke patients in the
early phase
S. Borsje, J.B.H. Hochstenbach, K. Postema, T. Mulder, University Hospital
Groningen, The Netherlands
14 The European PFO Data Registry (EUROPFORE)
M.G. Hennerici, European PFO Data Registry, Dept. of Neurology,
Klinikum Mannheim, RFK University Heidelberg, Germany
15 Motivational interviewing: altering outcome after stroke
C. Sutton, H. Dickinson, M. Leathley, K. Hills, M. Auton, E. Lightbody,
H. Gardner, C. Jack, M. van den Broek, C. Watkins, University of Central
Lancashire, United Kingdom
103

Poster Sessions Friday, May 23, 2003
104
16 PC-Trial – Patent Foramen Ovale and Cryptogenic Embolism
H.P. Mattle, B. Meier, S. Windecker, PC-Trial Study Group, Inselspital,
Switzerland
17 Safe Implementation of Thrombolysis in Stroke – Monitoring Study
(SITS-MOST)
N.G. Wahlgren, A. Davalos, C. Fieschi, M. Grond, W. Hacke, M. Kaste,
V. Larrue, K.R. Lees, Karolinska Hospital, Sweden
18 The CICA Study
J. Castillo, J. Matías-Guiu, E. Díez-Tejedor, E. Martínez Vila, CICA Study,
Hospital Clínico Universitario de Santiago de Compostela, Spain
19 Prevention Regimen For Effectively avoiding Second Strokes
(PRoFESS): rationale and design
H.C. Diener, PRoFESS Collaborative Group, University of Essen, Germany
20 Age-related white matter changes are correlated with gait
disturbances in cross-section analysis – preliminary results of the
LADIS (leukoaraiosis and disability) project
H. Baezner, C. Blahak, M.G. Hennerici, J. Bogousslavsky, D. Inzitari, LADIS
Study Group, Department of Neurology, Mannheim University Hospital,
Heidelberg University, Germany
21 Basilar Artery International Cooperation Study (BASICS)
W.J. Schonewille, A. Algra, L.J. Kappelle, C.A. Molina, C.A. Wijman,
University Medical Center Utrecht, The Netherlands
22 Aortic Arch Related Cerebral Hazard (ARCH)
G.A. Donnan, ARCH Steering Committees, National Stroke Research Institute,
Australia
23 Stroke patients in rehabilitation
J.A. Mirallas, A. Beltrán, T. Ricarte, F. Torralba, C. Trenor, A. Soler,
Stroke patients cost in Rehabilitatión, Hospital General de Castellón, Spain
24 Efficacy of nitric oxide in stroke (ENOS) trial – a prospective
randomised controlled trial in acute stroke
P.M. Bath, ENOS Investigators, Nottingham University, United Kingdom

25 FOOD (Feed Or Ordinary Diet): a “family” of three randomised trials
evaluating feeding policies for patients admitted to hospital with a
recent stroke
M.S. Dennis, International Stroke Trials (IST) Collaboration – FOOD,
University of Edinburgh, United Kingdom
26 CLOTS (Clots in Legs or TEDS after Stroke). A randomised trial to
establish the effectiveness of graduated compression stockings to
prevent post stroke deep vein thrombosis (DVT)
A.M.S. Dennis, University of Edinburgh, Dept. of Clinical Neurosciences,
Western General Hospital, Edinburgh, United Kingdom
27 The correlation between TCD findings and cerebral angiography with
percutaneous transluminal balloon angioplasty in the stenotic middle
cerebral artery
K.H. Cho, B.C. Kim, M.K. Kim, J.J. Seo, J.K. Kim, K.H. Cho, Department of
Neurology and Diagnostic Radiology, Chonnam National University Medical
School, South Korea
28 The International Carotid Stenting Study
M.M. Brown, R.L. Featherstone, The National Hospital for Neurology and
Neurosurgery, United Kingdom
29 Perfusion-CT guided intravenous thrombolysis after
3 to 6 hours: Feasability and safety study
P. Michel, M. Wintermark, M. Reichhart, F. Vingerhoets, R. Meuli,
J. Bogousslavsky, Centre Hospitalier Universitaire Vaudois, Switzerland
105

Instructions for Authors
Oral Presentations
All lecture rooms are equipped with a PC and a data projector for PowerPoint presentations.
The use of laptops in the lecture rooms is not possible.
PowerPoint presentations must be handed in via floppy disk, CD-ROM, zip drive or via your
own laptop at the Speakers Service Centre (SSC).
It is essential for the smooth running of the conference that all speakers hand in their
presentations at least one hour before the beginning of their lectures. Speakers will
have the opportunity to review their presentations on PCs available in the SSC.
The SSC is located on the ground floor of the conference centre, between Auditorium I and
Auditorium II.
106

Poster Presentations
Please note the following times for the presentation of your poster as well as for set-up
and removal:
Date of Session Preview Presentation Mounting Removal
session No. time time time time
Thursday, I 13.00– 16.00– 08.00– 18.00–
May 22 14.30 h 17.30 h 09.00 h 19.00 h
Friday, II 12.30– 16.00– 08.00– 18.00–
May 23 14.00 h 17.30 h 09.00 h 19.00 h
Authors are requested to be present at their posters during the presentation times
mentioned above.
Please note that the mounting and removal of the posters is in the responsibility of the
authors. Posters that have not been removed by the authors after 19.00 h will be removed
and disposed by the organisers.
Publication
All accepted abstracts are published in a supplement to Cerebrovascular Diseases and
on a corresponding CD-ROM according to the submission rules. Abstract booklet
and CD-ROM will be handed out to all registered participants at the registration desk.
107

Welcome Reception
Wednesday, May 21, 2003, as from 19.30 h
Welcome Reception
The Welcome Reception takes place in the stunning complex of cultural attractions known
as the City of Arts and Sciences which lies at the southern tip of the riverbed garden.
Eyeball-shaped L’Hemisfèric houses a planetarium, laserium, and IMAX theatre, and uses
hydraulic lifts to make the building's eyelid open and close. L’Hemisfèric will host the
participants of the 12 th European Stroke Conference for the Welcome Reception.
The Welcome Reception is sponsored by Ferrer Group.
108

Accompanying Persons Programme
Wednesday, May 21, 2003, 9.30–17.30 h
Requena
The city of Requena is located in the region of 'Plana de Utiel-Requena' in the province of
Valencia, renown for its monuments as well as its wine and sausage production.
We shall visit the district of ‘La Villa’, which was declared an Artistic-Historical National
Monument in 1966; the ‘Caves of La Villa’, which served as food warehouses, wine cellars
and refuge during various war periods; the Santa Maria Church, which was declared a
National Monument in 1931; as well as the wine cellar ‘Mas de Bazan’, which produces
excellent red and rosé wines.
Enjoy lunch in a typical local restaurant with wine, mineral water and coffee included.
In the afternoon we will visit the ‘Esther Mill’ located in Requena city. This grain mill dating
back to the 16 th century is the last functioning mill in Spain with hydraulic power.
On the way back to Valencia we will stop in ‘El Rebollar Natural Park’ which is well-known
for its great variety of Iberian peninsula fauna, from big Iberian bears to the small ‘gineta’.
A demonstration of birds of prey will be given.
Price / person: € 95
Meeting: 9.15 h outside the main entrance of the Palacio de Congresos
109

Accompanying Persons Programme
Thursday, May 22, 2003, 9.30–13.00 h
Valencia Sightseeing Tour Including the Historic Centre
Enjoy the city panorama as well as an in depth exploration of the historical centre on foot.
Delight in the charm of its streets, squares and hidden corners, discovering the Central
Market, a modernist building, with its abundant display of typical regional produce.
This tour will include visits to the Cathedral, the Miguelete Tower and the Lonja (declared
Patrimony of Humanity by the UNESCO).
Price / person: € 25
Meeting: 9.15 h outside the main entrance of the Palacio de Congresos
Friday, May 23, 2003, 9.30–13.30 h
The City of the Arts and Sciences
The City of the Arts and Sciences is an avant-garde construction for cultural and scientific
activities. The area is composed of several buildings of striking architectural quality
designed by Santiago Calatrava:
• Umbracle: a promenade
• Hemisferic: the only facility in Spain to project three audiovisual shows on a huge
concave screen of 900 square metres
• Museum of the Sciences Principe Felipe: a science and technology museum with
state-of-the-art, interactive contents that makes Valencia an outstanding international
landmark in the 21 st century
• Palace of the Arts and Oceanografic: currently under construction
Price / person: € 35
Meeting: 9.15 h outside the main entrance of the Palacio de Congresos
110

Saturday, May 24, 2003, 9.30 – 13.30 h
Visit to the Albufera National Park
Located 11 km south of the city and set between rice paddies and the sea, this area is
closed off by the geological embrace of the mouths of the Turia and Jucar Rivers.
The Albufera Natural Park is a paradise for migratory birds and a recreational area for
the city and its surrounding municipalities. We shall visit the following:
• The lookout point of the lake located next to the first lock on the 'El Saler' Road
• Raco de L’Olla Centre, an informative area with panels and audiovisuals about the
Albufera
• Interpretation area, for a closer look at the park's ecosystem
• Boat rides and optional lunch on the island of El Palmar, a quaint village closely
connected to the fishing trade
Price / person: € 40 (lunch not included)
Meeting: 9.15 h outside the main entrance of the Palacio de Congresos
General Remark
All tours are based on a minimum of 25 participants. If a tour does not take place due
to an insufficient number of participants, the ticket will be reimbursed in full. Otherwise
please note that tickets for excursions are non-refundable.
111

General Information (in alphabetical order)
Abstract Book
All accepted abstracts are published in a supplement to the journal Cerebrovascular
Diseases according to the submission rules. You will find a copy in your congress bag.
Badges
Access to all scientific sessions and to the exhibition is only possible with your personal
badge. All participants are requested to wear their name badges throughout the conference.
€ 20 will be charged for the replacement of a lost badge.
Banks
Banks are generally open from Monday to Friday from 8.30 or 9.00 h to 14.00 or 14.30 h.
Some banks open certain afternoons in the week. Almost every bank has a 24-hour cash
machine.
Cancellation / Refund Policy
Refund of registration fees, less 25% administrative charges, could have been applied for in
writing to the Administrative Secretariat until April 10, 2003. After this date no refund will be
possible.
Climate
At the end of May the climate is usually very pleasant with temperatures around 20 °C
during the day.
Correspondence after the Congress
ESC 2003 Phone +41 61 686 77 11
c/o AKM Congress Service Fax +41 61 686 77 88
PO Box E-mail info@akm.ch
Clarastrasse 57
CH-4005 Basel, Switzerland
112

Currency
The official currency in Spain is Euro (€). All congress prices are indicated in Euro.
All major credit cards are accepted in most hotels, restaurants and shops.
Electricity
The electrical power supply in Spain has 220 Volt (European standard plug).
Exhibition
An industrial exhibition takes place during the conference. Please also refer to the
exhibitors list on page 119.
Hotel Accommodation
AKM Travel is present at the Hotel Desk located in the registration area.
Insurance
The congress organisers cannot accept liability for personal injuries sustained, or for loss or
damage of property belonging to congress participants (or their accompanying persons),
either during or as a result of the congress. Please check the validity of your own insurance.
Internet Corner
Several Internet terminals are located in the exhibition area and are available to all
conference participants.
Language
The congress language is English. Simultaneous translation is not provided.
Mobile Phones
Please note that mobile phones must be switched off during all sessions.
113

General Information (in alphabetical order)
Opening Hours of the Conference Secretariat
The Conference Secretariat and Registration Desk at the Palacio de Congresos will be open
during the following hours:
Wednesday, May 21, 2003 12.00 – 18.00 h
Thursday, May 22, 2003 07.30 – 18.30 h
Friday, May 23, 2003 07.30 – 18.30 h
Saturday, May 24, 2003 08.00 – 14.00 h
Poster Exhibition / Poster Lunches
The poster exhibition is located on the 2 nd floor of the conference centre. For detailed
information on the poster sessions, please refer to pages 54–105.
Lunch (fingerfood) will be offered to the participants during the poster preview times
on Thursday and Friday in the restaurant on the 1 st floor.
Press
The press centre is located on the ground floor of the conference centre.
On-Site Registration Fees
Participants
Junior delegates
€ 600
(born after 31.12.1969) * € 400
Teaching Courses free
Accompanying persons € 60
* Proof required
114

The fees for conference participants include:
• Congress bag
• Final Programme / Abstract Book
• Admission to all scientific parts of the congress and the exhibition
• Welcome Reception
• Coffee breaks
• Poster lunches
The fees for accompanying persons include:
• Welcome Reception
• Valencia sightseeing tour
Onsite registrants cannot be guaranteed to receive all congress documents.
Restaurants
Sun and oranges, delicious seafood, vegetables and very good wines (D.O. Utiel-Requena
and Valencia) – those are the catchwords characterising one of the finest cuisines of Spain.
Also rice, which is produced here in large quantities, is a protagonist in many typical dishes.
The Valencianos understand to combine those ingredients to perfect masterpieces, Paella
Valenciana being the most famous example.
Shopping Hours
Shops are generally open from 10.00–14.00 h and from 17.00–20.00 h, Mondays through
Saturdays. Department stores and malls are usually open from 10.00–21.00 h and do not
close during lunchtime.
Time
Spain is 1 hour ahead of Greenwich Mean Time (GMT).
115

General Information (in alphabetical order)
Transportation Tickets
Valencia is covered by an extensive public transportation network, including four metro
lines and public buses which travel to any part of the city. Apart from the single tickets,
which can be bought at the metro stations and on the buses, there also are 1-day and 3-day
tickets available which are sold at the Hotel Desk at a price of € 6 and € 12 respectively.
Valencia
Valencia is a vibrant, cosmopolitan city on the Mediterranean coast. Once the capital of its
own kingdom, it now is a regional capital and Spain’s third largest city. Surrounded by
immense orange orchards and sandy beaches, the city enjoys year-round sunshine and has
become a popular business centre.
The city was founded by the Romans, taken by the Visigoths, and prospered under the
Moors. Each civilisation has left its mark: The historic centre includes a 13 th century
cathedral (La Seo) with paintings by Goya and a splendid gothic 15 th century silk exchange
(La Lonja). However, the city is looking to the future and is now home to one of Europe’s most
exciting urban development projects. Some USD 200 million has been invested in building
the immense and futuristic City of the Arts and Sciences (Ciutat de les Arts i les Ciencies)
which is located near the port.
Valencia means commerce and culture, cinema, theatre, museums, music and business.
It is a centre for industrial design and avant-garde movements. Valencia is a city that never
sleeps, with an extensive cultural line-up.
During your stay in Valencia, you will also be able to enjoy the peace and quietness of
several exceptional natural sites. Between the sea and the rice paddies, closed in by two
river mouths, the Albufera Natural Park is a paradise for migratory birds and a recreation
area for the city. Along the coast next to the Albufera there are broad sandy beaches.
Venue
Palacio de Congresos
Avda. Cortes Valencianas, 60
E-46015 Valencia, Spain
The Palacio de Congresos is built by the world famous architect Norman Foster and an
experience of its own.
116

Notes
117

Conference Venue Overview
2 nd Floor
Poster Exhibition
1 st Floor
Committee Rooms (Teaching Courses / Meetings)
Poster Lunches
Ground Floor
Auditorium I, II and III
Speakers Service Centre SSC
Exhibition
Internet Corner
Registration / Secretariat / Hotel Desk
Press Room
Cafeteria / Cash Bar
118

List of Exhibitors (in alphabetical order)
127 5th World Stroke Congress, Vancouver / Canada
125 Bayer HealthCare, Leverkusen / Germany
103 Bioscience Ediprint Inc., Geneva / Switzerland
113 Boehringer Ingelheim, Ingelheim / Germany
126 Cerebricon Ltd., Kuopio / Finland
131 DWL Elektronische Systeme GmbH, Sipplingen / Germany
102 European Association of Young Neurologists Trainees – EAYNT
107 European Federation of Neurological Associations – EFNA, Vienna / Austria
107 European Federation of Neurological Societies – EFNS, Vienna / Austria
106 European Stroke Initiative – EUSI, Helsinki / Finland
105 Ferrer Group, Barcelona / Spain
101 Grupo Uriach, Barcelona / Spain
133 MSD, Madrid / Spain
121 NMT Medical Inc., Boston MA / USA
129 Novo Nordisk, Bagsvaerd / Denmark
109 S. Karger AG, Basel / Switzerland
111 Sanofi-Synthélabo / Bristol-Myers Squibb, Paris / France
123 SITS International, Stockholm / Sweden
Bookdisplay
Wisepress Bookshop, London / United Kingdom
119

Exhibition and Conference Venue Plan
120
Cash
Bar
101
103
102
105
106
109
107
Auditorium I
111
113

Speakers
Service
Centre
121 123
121 123
125
126
Auditorium II
127
129
131
133
Auditorium III
121

Valencia Sights
122

1. City HalI
2. Flower Market
3. Post Office
4. Main Theatre
5. Bullfighting Museum
6. Bullring
7. Train Station
8. St Augustine Church
9. Cultural Centre. Former Hospital
for the Poor
10. Santa Lucia Chapel
11. Craftsmanship Centre
12. Church of the Pilar
13. St Sebastian Parochial Church
14. Quart Towers
15. Botanical Gardens
16. La Beneficencia Cultural Centre
17. Marquis de Campo Asylum
18. Valencian Institute of Modern Art
19. Jose Benlliure Home Museum
20. El Carmen Church
21. El Carmen Art Centre
22. La Pineda Palace
23. Puente de Madera Station
(Trams to beaches)
24. Turia Gardens
25. San Pio V Fine Arts Museum
26. Royal Gardens or Los Viveros
27. Monforte Gardens
28. Paseo de la Almeda
29. Serranos Towers
30. Casa de las Rocas
31. Valldigna Portal
32. Church of St Nicholas
33. Benicarlo Palace. Seat of the
Valencian Parliament
34. Baylia Palace. Seat of the
Provincial Council
35. Marques de Scala Palace
36. Palau de la Generalitat
37. Basilica of Our Lady of the
Forsaken
38. Cathedral complex:
Cathedral, Miguelete Tower,
Holy Grail Chapel
39. Archbishop's Palace
40. Crypt of St Vicente the Martyr
41. Marquis de Campo Palace.
City Museum
42. Royal Monastery of the Trinity
43. Almudin (13 th century city
granary)
44. Escriva Palace
45. Church of St John of the Hospital
46. St Thomas and San Felipe Neri
Church
47. Former Santo Domingo Convent.
Levante Regional Military Govt.
48. Civil Government
49. Church of the Temple
50. Birthplace of San Vicente Ferrer
51. Tourist Office, Cal le Paz
52. La Glorieta Gardens
53. Courthouse
54. Parterre Gardens
55. Patriarch's Seminary
56. Old University of Valencia
57. Church of St John of the Cross
58. Palace of the Marquis of Dos
Aguas. Gonzalez Martií National
Ceramics Museum
59. St Martin’s Church
60. Plaza Redonda
61. Church and Belltower of
St Catherine
62. The Silk Exchange and Maritime
Consulate (World Heritage)
63. The Central Market
64. Santos Juanes Church
123

Notes

Notes

Notes

Notes

Notes
Printed in Switzerland A15668 IR.04.2003/3.0